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Resumo 
O modelo de sinapse actualmente aceite considera que para o processo de comunicação 
neuronal contribuem não só os neurónios pré- e pós-sináptico mas também um elemento 
peri-sináptico, os astrócitos. Estes constituem a população de células mais abundante no 
cérebro, formando juntamente com a micróglia e os oligodendrócitos a rede de células da 
glia. Presentemente, sabe-se que os astrócitos não são meros elementos passivos, 
comunicando activamente com as outras células através do seu mecanismo de 
excitabilidade que usa iões de cálcio (Ca2+) como mensageiro interno para desencadear a 
gliotransmissão. Este fenómeno é despoletado pela activação de receptores 
membranares e consiste na libertação de gliotransmissores (GT) como o glutamato, ATP e 
D-serina. A libertação de GT parece exercer uma função com características em certa 
medida semelhantes à libertação de neurotransmissores (NT) pelos neurónios.  
Esta conversa dinâmica e bidireccional entre neurónios e astrócitos depende da libertação 
de NT e GT que são reconhecidos por ambos os tipos de células. Desta forma, a libertação 
de NT do terminal pré-sináptico afecta o terminal pós-sináptico mas também os astrócitos 
envolventes, induzindo um aumento nos seus níveis intracelulares de Ca2+ [Ca2+]i. Em 
resposta, os astrócitos libertam GT, por um mecanismo não complemente elucidado, 
afectando novamente o terminal pós-sináptico e ainda a libertação de NT do terminal pré-
sináptico. Através destes mecanismos, os astrócitos modulam a excitabilidade neuronal e 
a transmissão sináptica, havendo evidências de que também modulam fenómenos como 
a potenciação de longa duração que está intimamente ligada à memória e aprendizagem.  
As purinas, nomeadamente o ATP e a adenosina, modulam a gliotransmissão, regulando a 
transmissão sináptica e a comunicação neurónio-astrócito. O ATP desencadeia a 
sinalização por Ca2+, sendo um dos agentes dos primeiros eventos no processo de 
gliotransmissão em astrócitos. O aumento da [Ca2+]i mediado pelo ATP deve-se à 
activação de receptores metabotrópicos (P2YR), que levam à libertação de Ca2+ dos 
compartimentos intracelulares via fosfolipase C (PLC) e inositol (1,4,5)-trifosfato (IP3), e de 
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receptores ionotrópicos (P2XR), que medeiam a entrada directa de Ca2+ do exterior da 
célula.  
O ATP é convertido extracelularmente em adenosina e ambas as purinas se acumulam 
simultânea ou sequencialmente, estando os seus níveis aumentados em situações 
patológicas. Os receptores para o ATP (metabotrópicos P2YR e ionotrópicos P2XR) e para 
a adenosina (metabotrópicos A1R, A2AR, A2BR e A3R) são coexpressos nos astrócitos, o que 
sugere uma possível interacção entre estas duas famílias de receptores. Da família dos 
receptores de ATP, o P2Y1R exerce um papel preponderante no desencadear da 
gliotransmissão. Sabe-se que a adenosina modula a sinalização de Ca2+ desencadeada por 
neurotransmissores e neuromoduladores como o glutamato e ATP, no entanto, não se 
compreende completamente quais os receptores de adenosina envolvidos neste 
processo. É de salientar ainda que os receptores A1 estão negativamente acoplados ao 
AMP cíclico (cAMP) através de uma proteína Gi inibitória, diminuindo a libertação de GT. 
Os receptores A2A estão positivamente acoplados ao cAMP através de uma proteína Gs 
estimuladora, potenciando a libertação de GT.  
Estudos anteriores mostram que a adenosina modula diferencialmente a internalização 
de GABA em astrócitos corticais através dos seus receptores membranares de alta 
afinidade A1 e A2A. É de salientar que esta modulação depende da cooperação entre os 
receptores A1 e A2A.  
O principal objectivo deste trabalho é avaliar o papel dos receptores de adenosina, em 
particular do A2A, na modulação da sinalização por Ca
2+. Pretende-se também explorar a 
possível cooperação entre os receptores A1 e A2A de adenosina no efeito modulatório.   
As respostas de Ca2+ em astrócitos corticais primários foram estudas pela técnica de 
imagiologia de Ca2+, usando um microscópio invertido de epifluorescência. O fluoróforo 
escolhido foi o Fura-2AM que é altamente sensível ao Ca2+, ligando este ião de forma 
estável e reversível. Trata-se de um fluorocromo raciométrico, uma vez, que sofre um 
desvio no comprimento de onda do pico de absorvência quando ligado ao Ca2+, de 380 
(F380) para 340 (F340) nm. O rácio F340/F380 é usado para avaliar as variações da [Ca2+]i. 
A internalização do fluoróforo processa-se durante 45 minutos a 37oC e ocorre de forma 
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passiva devido aos grupos AM que atribuem carga global negativa. Já dentro da célula, os 
grupos AM são clivados por enzimas e o fluoróforo fica retido no interior da célula.  
As células foram local e brevemente (0,2 segundos) estimuladas com 10 μM ATP, a 22 oC, 
e a amplitude das respostas foi medida na presença de diferentes fármacos. Foi usado um 
análogo estável da adenosina, 2-cloroadenosina (CADO), um agonista e um antagonista 
selectivos para o receptor A2A, CGS 21680 e SCH 58261, respectivamente, e um 
antagonista selectivo para o receptor A1, DPCPX. No protocolo desenvolvido e optimizado 
no decurso do projecto, as células foram estimuladas de 5 em 5 minutos e obteve-se 
respostas para a situação controlo, apenas com tampão HEPES no meio, de seguida na 
presença do fármaco, que é mantido no meio de perfusão no mínimo durante 15-20 
minutos, seguindo-se finalmente a lavagem com tampão HEPES ou com uma mistura de 
agonista/antagonista do receptor. Como controlo interno, foi ainda obtida a resposta 
máxima da célula a um estímulo supramáximo, 100 μM ATP. 
O desenvolvimento deste protocolo dependeu da optimização de uma serie de 
parâmetros como o período de intervalo entre estimulações, a concentração de ATP 
usada como estimulo, a duração de cada estimulação, a temperatura da incubação com o 
fluoróforo e a temperatura de perfusão usada durante toda o registo de sinais de Ca2+. 
As culturas primárias foram caracterizadas quanto às populações de células presentes, 
astrócitos, neurónios e micróglia, pela técnica de imunocitoquímica, recorrendo a 
anticorpos que marcam especificamente estas células. Detectou-se ainda a presença dos 
receptores de ATP, P2Y1, e de adenosina, A1 e A2A, pela técnica de western blot, aplicando 
anticorpos específicos para estas proteínas.      
Observei que a estimulação breve com 10 μM ATP (0,2 segundos) induz um transiente de 
Ca2+ rápido. A estimulação prolongada (≥ 20 segundos) com ATP induz uma resposta de 
Ca2+ bifásica, constituída por um pico inicial, seguindo-se um patamar na resposta. 
Segundo outros autores, o pico inicial é mediado por receptores P2Y e o patamar por 
receptores P2X. O envolvimento dos receptores P2Y no pico inicial foi comprovado na 
presença de baixa concentração de Ca2+ extracelular.   
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O análogo estável da adenosina que apresenta afinidade semelhante para os receptores 
A1 e A2A, 1 μM CADO, potenciou marcadamente a resposta de Ca
2+ desencadeada pelo 
ATP (aumento da resposta: 3,19 ± 0,30 vezes, n=72 células). O agonista selectivo para o 
receptor A2A, 30nM CGS 21680, imitou este efeito (2,92 ± 0,32 vezes, n=80 células). Estes 
efeitos foram completamente revertidos após remoção do agonista do meio de perfusão. 
O parâmetro ‘aumento da resposta’ é o rácio entre a amplitude da resposta ao ATP na 
presença do fármaco e a amplitude da resposta na ausência de fármaco. Foi ainda 
calculado o parâmetro ‘resposta controlo/resposta máxima’, tendo observado uma 
relação inversa entre os valores de aumento de resposta e resposta controlo/resposta 
máxima. Desta forma, as células que apresentam uma menor resposta controlo em 
relação à resposta máxima, determinada na presença de 100 μM ATP, sofrem um 
aumento mais elevado induzido pelos agonistas, CADO e CGS 21680. Tal variabilidade de 
respostas mostra que estamos perante uma população de células heterogéneas.  
Para estudar a possível cooperação e/ou interacção entre os receptores A1 e A2A, foram 
usados antagonistas específicos para estes receptores de forma a testar se revertiam a 
potenciação induzida pelos agonistas. Verifiquei que os antagonistas, 50 nM SCH 58261 e 
50 nM DPCPX, por si só, não induziam variação apreciável na resposta de Ca2+. 
Surpreendentemente, a potenciação induzida pelo CADO (agonista não-selectivo A1 e A2A) 
e pelo CGS 21680 (agonista selectivo A2A) foi completamente revertida não só pelo 
antagonista específico do receptor A2A, SCH 58261, mas também pelo antagonista 
específico do receptor A1, DPCPX. Tais resultados mostram que a activação de ambos os 
receptores, A1 e A2A, é fundamental para que o efeito modulatório se verifique, sugerindo 
a cooperação entre estes receptores. 
A caracterização das culturas primárias pela técnica de imunocitoquímica mostrou que 
estas são constituídas maioritariamente por astrócitos (> 90%) e alguma micróglia. Desta 
forma, pode-se afirmar que estamos perante culturas primárias enriquecidas em 
astrócitos. A introdução de um passo extra de agitação ao dia 6 de cultura, antes de 
replaquear as células, permite obter culturas com uma maior percentagem de astrócitos 
(> 95%) em relação à micróglia. 
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Recorrendo à técnica de western blot foi possível detectar a presença dos receptores de 
ATP, P2Y1, e de adenosina, A1 na cultura enriquecida em astrócitos. No entanto, usando 
esta técnica, não foi possível detectar os receptores A2A de adenosina. Uma vez, que a 
presença de receptores A2A já foi observada anteriormente em astrócitos corticais e que 
pela técnica de imagiologia de Ca2+, aqui aplicada, foram obtidas respostas a fármacos 
específicos para estes receptores, pode-se afirmar que estes receptores estão presentes 
nas culturas primárias usadas neste estudo. Provavelmente a sua densidade será baixa e 
desta forma difícil de quantificar por western blot.    
Os resultados aqui apresentados permitem concluir que a adenosina, através da activação 
de receptores A2A, facilita a sinalização por Ca
2+ induzida pelo ATP, em astrócitos corticais. 
Mais ainda, a cooperação entre os receptores A1 e A2A, parece ser essencial para a 
modulação observada. 
O envolvimento de receptores A2A na modulação da sinalização de Ca
2+ aqui demonstrado 
contrapõe resultados anteriores nos quais outros autores mostraram que estes 
receptores não tinham qualquer efeito sobre a modulação das respostas de Ca2+. Esses 
autores mostraram ainda que os receptores A2B de adenosina medeiam a modulação da 
sinalização por Ca2+. No entanto, no trabalho anterior foram usadas concentrações de 
fármacos não selectivas para os receptores correspondentes, o que poderá justificar as 
diferenças nos resultados obtidos. 
Os resultados aqui apresentados estão de acordo com o modelo tetramérico -  A1-A1-A2A-
A2A - de receptores de adenosina proposto para a modulação diferencial da internalização 
de GABA pela adenosina, em astrócitos corticais. Os resultados aqui obtidos apoiam um 
cenário semelhante para a modulação da sinalização de Ca2+ pela adenosina com possíveis 
implicações na libertação de GT. Trata-se por isso de um novo mecanismo de modulação 
sináptica indirecto que é provavelmente mediado pela cooperação dos receptores A1 e 
A2A de adenosina, permitindo uma regulação apertada e uma transição suave entre os 
estados inibitório e potenciador.  
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Abstract 
Purines, namely ATP and adenosine, modulate gliotransmission, regulating synaptic 
transmission and ultimately neuron-astrocyte communication. ATP triggers the signalling 
of free calcium ions (Ca2+), which is the substrate for gliotransmission, in astrocytes. ATP is 
extracellularly converted into adenosine and both purines can be accumulated 
simultaneously or sequentially, acting on a plethora of membrane astrocytic receptors. 
Adenosine modulates GABA uptake in cortical astrocytes through A1 (A1R) and A2A (A2AR) 
receptors. Most importantly, this modulation is dependent on tight A1R-A2AR cooperation. 
Therefore, the aim of this project was to evaluate the role of adenosine receptors, mainly 
A2AR, in Ca
2+ signalling modulation and also to explore the possible cross-talk between A1R 
and A2AR in this modulation.  
Ca2+ responses of cortical primary astrocytes were studied by Ca2+ imaging technique 
using Fura-2AM, at 22oC. Cells were locally and briefly (0.2 seconds) stimulated with 10μM 
ATP and the amplitude of fluorescence signals was measured in the presence of different 
drugs. Cultures were further characterized by immunocytochemistry and western blot 
techniques. 
A stable adenosine analogue, 2-Chloroadenosine (1 μM), markedly enhanced ATP-induced 
Ca2+ responses (fold increase: 3.19 ± 0.30, n=72 cells). An A2AR selective agonist, CGS 
21680 (30nM), mimicked this effect (2.92 ± 0.32, n=80 cells). The potentiation mediated 
by both agonists was not only completely reverted by an A2AR selective antagonist, SCH 
58261 (50nM), but also by an A1R selective antagonist, DPCPX (50nM).  
Primary enriched astrocytic cultures are constituted mainly by astrocytes (> 90%) and 
microglial cells. The presence of ATP, P2Y1R, and adenosine, A1R, but not A2AR could be 
demonstrated for primary astrocytic cultures. Nevertheless, selective agonists and 
antagonist used in Ca2+ imaging have proven the presence of functional A2AR.  
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It is concluded that adenosine, through A2AR activation, potentiates ATP-induced Ca
2+ 
signalling in astrocytes. Furthermore, A1R-A2AR cooperation seems to be required for this 
modulation. 
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Abbreviation List 
A1R   A1 adenosine receptor 
A2AR  A2A adenosine receptor 
AC  adenylate cyclase 
ADO adenosine 
ADOR adenosine receptors 
ADA  adenosine deaminase 
ADP  adenosine 5’-diphosphate 
AMP adenosine 5’-monophosphate 
AMPAR  2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid receptor 
ATP  adenosine 5’-triphosphate 
BAPTA  1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 
Ca2+  free calcium ion  
[Ca2+]i  intracellular free calcium ion concentration 
CADO  2-chloro-adenosine 
cAMP  cyclic adenosine 5’-monophosphate 
CGS 21680  4-[2-[[6-amino-9-(N-ethyl-β-Dribofuranuronamidosyl)-9H-
purinyl]amino]ethyl]benzenepropanoic acid hydrochloride 
DIC  days in culture 
DMEM  Dulbecco’s Modified Eagle’s Medium  
DPCPX  8-cyclopentyl-1,3-dipropylxanthine 
EGTA  ethyleneglycol bis(β-aminoethylester)-N,N,N’,N’-tetraacetate  
F340  fluorescence at 340 nm 
F380  fluorescence at 380 nm 
F340/F380  fluorescence ratio at 340 nm over 380 nm 
FBS  Fetal Bovine Serum 
Frest  resting fluorescence   
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Fmax  maximal fluorescence 
Fmin  minimum fluorescence 
Fura-2AM  Fura-2 acetoxymethyl Ester 
Fzero  zero fluorescence (autofluorescence) 
GT  gliotransmitter  
IP3  inositol triphosphate 
Kd  dissociation constant 
NMDAR  N-methyl D-aspartate receptor 
NT  neurotransmitter  
LTP  long-term potentiation 
LTD  long-term depression  
P2YR  P2Y (ATP) receptor 
P2XR  P2X (ATP) receptor 
PBS  phosphate buffered saline 
PFA  paraformaldehyde 
PKA  protein kinase A 
PKC  protein kinase C 
PLC  phospholipase C 
RT room temperature (22oC) 
SCH 58261  (2-(2-furanyl)-7-(2-phenylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-
c]pyrimidin-5-amine 
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1 Introduction 
1.1 Astrocytes 
More than 150 years ago, in 1856, Rudolf Virchow introduced the concept of neuroglia as 
connective material that supports the true nerve cells, neurons (Kettenmann & 
Verkhratsky, 2008). The word glia, Greek for ‘glue’, was used to designate cells that bring 
neurons together. This idea persisted throughout the 20th century, as astrocytes were 
shown to be electrically nonexcitable, in contrast to neurons. This paradigm has only 
begun to change in the last two decades with the emerging of calcium imaging techniques 
and the discovery of astrocytic calcium ion (Ca2+) excitable mechanism (Agulhon et al., 
2008).  
The word astrocyte was introduced in 1893, by Michael von Lenhossek, to designate glial 
cells with a stellate morphology (reviewed by Matyash & Kettenmann (2010)). Prior to 
that there was no differentiation between astrocytes, microglial cells and 
oligodendrocytes, which constitute the glial cell family.  
Astrocytes are the most abundant cell population in the brain and currently they are no 
longer seen as mere supportive elements. Throughout the years different roles were 
proposed for astrocytes. Camillo Golgi suggested that astrocytes provide metabolic 
support to neurons. Followed by the acknowledgement that astrocytes control blood 
flow, homeostasis of the extracellular milieu and synaptogenesis (Kettenmann & Ransom, 
2005). Very recently, astrocytes were recognized as active elements in cell 
communication, which are intimately involved in control of brain function. Glial regulation 
of neuronal communication had already been proposed by Carl Ludwig Schleich, in 1898 
(see Kettenmann & Verkhratsky (2008)), but back then astrocytes were not envisioned as 
integral elements of important brain functions. 
The word astrocyte is normally used as a general designation, but it actually refers to cells 
from the central nervous system since there are other specialized astrocytes. They are the 
Bergmann glia, in cerebellum and Müller cells, in retina (Newman, 2003).   
Introduction 
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Presently, astrocytes are known to express a plethora of membrane receptors, which 
recognize neurotransmitters that modulate astrocytic functions. Furthermore, astrocytes 
themselves release a number of signalling molecules to influence other cells and also 
transmit messages through the glial web of connections (reviewed by Hamilton & Attwell 
(2010)). Astrocytes also take up neurotransmitters, such as glutamate and GABA, 
regulating their extracellular levels. Consequently, these cells modulate synaptic activity 
and plasticity (reviewed by Perea & Araque (2010)), a characteristic that was for a long 
period of time only related to neurons. 
In pathological situations astrocytes undergo reactive gliosis, characterized by 
proliferation and cellular hypertrophy, forming the glial scar that isolates the lesion site, 
avoiding axon regrowth but also secondary damage (James & Butt, 2002).  
 
 
1.1.1 Type-I and Type-II astrocytes 
In the 19th century, it was already recognized that astrocytes are a heterogeneous cell 
population divided into two classes, protoplasmic (Type-I) and fibrous (Type-II) (reviewed 
by Matyash & Kettenmann (2010)). The terms protoplasmic and fibrous were introduced 
by Andriezen (1893) and Kölliker (1889), respectively, and are related to cell morphology.  
Type-I astrocytes are found mostly in grey matter. Their large projections enwrap 
synapses and express neurotransmitter receptors, transporters and ion channels. Type-II 
astrocytes are more abundant in white matter and present numerous fine finger-like 
projections that form points of contact with nodes of Ranvier of the neuronal network. 
They also express ion channels and transporters, and probably neurotransmitter 
receptors. Other than morphological differences, namely, functional differences between 
these two types of cells are not well understood (Matyash & Kettenmann, 2010). 
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(a) (b)
  
Figure 1.1 - An earliest illustration of (a) protoplasmic (b) fibrous astrocytes in central nervous 
system by Del Rio-Hortega from 1920. Image from Verkhrtsky et al. (1998). 
 
 
1.2 Tripartite Signalling 
For the past two decades, evidences have been accumulated showing that astrocytes 
have an active role in the brain, “listening” and “talking” to synapses. Recently, this 
dynamic two-way conversation between astrocytes and neurons at the synapse led to the 
postulation of a new concept, the tripartite synapse, in opposition to the previous 
bipartite paradigm. The term tripartite signaling was first introduced by Alfonso Araque 
and considers that communication at synaptic level involves pre- and post-synaptic 
neuronal elements as well as peri-synaptic elements, the astrocytes (Araque et al., 1999).  
In the early 1990s, astrocytes were first found to respond to membrane receptor 
activation with an increase in intracellular Ca2+ levels ([Ca2+]i) (Salm & McCarthy, 1990). 
Around the same time, independent works showed that extracellular stimuli, such as 
glutamate, evoked an intracellular Ca2+ rise in astrocytes, followed by a Ca2+ wave 
throughout the glial network (Cornell-Bell et al., 1990; Charles et al., 1991; Porter & 
McCarthy, 1996). In the same decade, other research groups demonstrated that Ca2+ 
responses in astrocytes induced a similar Ca2+ rise in nearby neurons (Nedergaard, 1994; 
Introduction 
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Parpura et al., 1994; Pasti et al., 1997). These were the first steps to unveil the complex 
bidirectional communication between neurons and astrocytes.  
 
  
Figure 1.2 - Release of neurotransmitter from the pre-synaptic terminal not only affects the post-
synaptic terminal but also the peri-synaptic component, the astrocytes, inducing an intracellular 
Ca
2+
 rise. In return, astrocytes release gliotransmitters that can exert its effect onto the post-
synaptic terminal or can feedback onto the pre-synaptic component. Image from Allen & Barres 
(2009). 
 
 
1.2.1 Ca2+  signalling and gliotransmission  
As astrocytes were shown to present Ca2+ oscillations, an entire new Ca2+ excitable 
mechanism was unveiled. Now it is know that astrocytes release signalling molecules, 
gliotransmitters, such as glutamate, GABA, ATP, adenosine and D-serine, in response to 
mechanical or neurotransmitter stimuli (Hamilton & Attwell, 2010). Inversely, 
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gliotransmitters modulate neuronal excitability and synaptic transmission both onto the 
pre- and post-synaptic terminals (Figure 1.2) (Perea & Araque, 2010).  
Gliotransmission is prompt by rapid [Ca2+] rise in the citosol, which is a consequence of 
membrane receptor activation, such as, purinergic ATP receptors (Fields & Burnstock, 
2006), as will be discussed later. This pathway is activated via membrane metabotropic 
receptors associated to G proteins, which stimulate phospholipase C (PLC) and formation 
of inositol (1,4,5)-triphosphate (IP3) and consequently Ca
2+ release from the endoplasmic 
reticulum. Ionic channels are also activated, allowing direct Ca2+ entry from the 
extracellular milieu (reviewed by Scemes & Giaume (2006)).  
In physiological conditions, cytosolic [Ca2+] is maintained at low levels (≈ 100 nM) 
compared to [Ca2+] in intracellular storages, which can reach hundreds of mM (Barhoumi 
et al., 2010). The concentration of this intracellular second messenger is tightly regulated 
in time and space within the cell. Perturbations of intracellular Ca2+ homeostasis normally 
lead to cellular dysfunction and cytotoxicity (Verkhratsky et al., 1998).   
The rapid and brief rise in [Ca2+]i, in response to an external stimulus, triggers 
gliotransmission and many other cellular processes that derive from Ca2+ signalling. 
Although the molecular mechanisms are not fully comprehended, Ca2+ signalling seems to 
be a specific form of cellular excitability that can be compared to electrical responses in 
neurons (Scemes & Giaume, 2006).  
Distinct forms of Ca2+ signalling were observed and vary from spontaneous Ca2+ 
oscillations in individual cells to coordinated forms as intracellular Ca2+ waves that 
propagate throughout the brain (Scemes & Giaume, 2006). Depending on the level of 
neuronal activity, Ca2+ response remains restricted to one cell or propagates to other glial 
cells (Fellin & Carmignoto, 2004). Due to this fast mechanism of propagation of Ca2+ 
response, astrocytes were proposed to modulate and synchronize neuronal activity in 
large areas of the brain (Fellin et al., 2004; Halassa et al., 2006). Therefore, Ca2+ signalling 
can be seen as a non-synaptic type of communication between distant neurons. 
Interestingly, astrocytes can also initiate Ca2+ transients in the absence of neurons, which 
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suggests that this phenomenon has other roles beyond transmission of neuronal 
information throughout the glial network (Aguado et al., 2002; Nett et al., 2002). 
There is little evidence to suggest the actual existence of Ca2+ waves in intact tissues ‘in 
situ’ or ‘in vivo’ during physiological levels of activity (Agulhon et al., 2008). Nevertheless, 
spontaneous Ca2+ variations and neurotransmitter-induced Ca2+ oscillations were detected 
in vivo (Hirase et al., 2004). Furthermore, Ca2+ elevations were observed in response to 
whisker stimulation, a physiological sensory stimulus (Wang et al., 2006). These results 
highly support the idea that neuron-astrocyte communication via Ca2+ signalling is present 
in vivo. 
The molecular mechanisms underlying gliotransmitter release from astrocytes are not 
well understood. Transporters, hemichannels, volume-activated channels and exocytosis 
are few of the mechanisms proposed (Hamilton & Attwell, 2010). Furthermore, evidences 
indicate that exocytosis depends on Ca2+ and SNARE proteins (Araque et al., 1998b), 
involves vesicles (Bezzi et al., 2004) and lysosome exocytosis (Zhang et al., 2007). 
Nevertheless, very recently, Agulhon et al. (2010) demonstrated that astrocytic 
modulation of hippocampal plasticity is not dependent on Ca2+-mediated gliotransmitter 
release mechanisms. Overall, it is very likely that several of these mechanisms co-exist, 
undergoing differential activation under distinct situations. 
 
 
1.2.2 Neuron-Astrocyte bidirectional communication 
Although, the nature of the mechanisms underlying gliotransmission remain controversial, 
it was proven that astrocytes control neuron-astrocyte communication, namely synaptic 
transmission and plasticity, through gliotransmission (Perea & Araque, 2010). Synaptic 
modulatory effects were both demonstrated at pre- and post-synaptic levels (Fiacco & 
McCarthy, 2004; Gordon et al., 2005). Modulation of synaptic transmission, by astrocytes, 
was observed in co-cultures of neurons and astrocytes (Parpura et al., 1994; Araque et al., 
1998a; Araque et al., 1998b), as well as, in brain slices (Pasti et al., 1997; Kang et al., 
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1998). This phenomenon was also demonstrated on other preparations, such as, the 
retina (Newman & Zahs, 1998) and the neuromuscular junction (Robitaille, 1998; Rochon 
et al., 2001).        
Neuronal plasticity is a well described phenomenon, important in processes underlying 
learning and memory. Long-lasting changes in astrocytic Ca2+ oscillations, induced by 
neuronal activity, were proposed (Pasti et al., 1995). However, the existence of an 
astrocytic plasticity in vivo is still a controversial subject.   
It is common knowledge that neurons exert their excitatory/inhibitory tonus using mostly 
glutamate/GABA neurotransmitters. Astrocytes also release glutamate as excitatory 
gliotransmitter but ATP, which is hydrolyzed into adenosine, is the inhibitory molecule 
(Halassa et al., 2006).  
Exciting results indicate that astrocytes not only detect synaptic information but also 
process it, producing a nonlinear response that is transmitted to adjacent synapses (Perea 
& Araque, 2006). Moreover, it was not only demonstrated that astrocytes discriminate 
different neurotransmitters from the same synaptic pathway (Araque et al., 2002), but 
also that they distinguish different synaptic pathways that use the same neurotransmitter 
(Perea & Araque, 2005). The fact that astrocytes recognize, internalize and release 
neurotransmitters seems to indicate that they are able to detect, integrate and respond 
according to neuronal activity. Therefore, for their importance in the process, transfer and 
storage of information in the nervous system, some authors suppose that astrocyte 
deregulation might contribute to an imbalance of neuronal excitability and ultimately to 
the development of disorders, such as epilepsy (Fields & Burnstock, 2006; Halassa et al., 
2006; Sebastião & Ribeiro, 2009b). 
These recent discoveries related to astrocytes are revolutionizing the way brain function is 
perceived and the classical paradigm that it results exclusively from neuronal activity is 
being questioned. Now we understand that brain function depends on concerted activity 
of a neuron-glia network, in which intra- and intercellular Ca2+ signalling in astrocytes are 
key elements. 
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1.3 Purinergic signalling in neuron-glia networks 
The word “purinergic” was firstly introduced in the 1970s by Geoffrey Burnstock, who 
advanced the concept of ATP as a neurotransmitter and a co-transmitter (Burnstock, 
1972). Few years later, 2 subtypes of purinergic receptors were proposed based on 
different ligands, adenosine (P1 receptors) and ATP/ADP (P2 receptors) (Burnstock, 1976). 
Afterwards it was proposed the separation of P1 (Van Calker et al., 1979) and P2 
(Burnstock & Kennedy, 1985) receptor families into subfamilies, which will be discussed 
below.  
Purines have long been recognized as extracellular messengers, mediating communication 
with the vascular network (Drury & Szent-Györgyi, 1929) but more recently they were also 
associated to heterotypic communication, between neurons and astrocytes (Koizumi et 
al., 2003; Zhang et al., 2003), as well as, to homotypic communication, among astrocytes 
(Guthrie et al., 1999).  
Purines also act as an intracellular messenger, regulating a broad scope of phenomena, 
such as, glial growth, proliferation, motility, survival and differentiation (Fields & 
Burnstock, 2006). Purines play a preponderant role in stress situations, when their 
extracellular concentration rises abruptly (Frenguelli et al., 2007).  Evidences even suggest 
that astrocytes sense the severity of damage by the amount of ATP released from damage 
cells (Fields & Burnstock, 2006).      
Purinergic signalling is far more complex than any other neurotransmitter, as ATP 
degradation produces other purines, namely ADP and adenosine, which can further 
activate P2R and P1R, respectively (Fields & Burnstock, 2006). From ATP release and 
enzymatic degradation to purinoceptor activation, different patterns of purinergic 
signalling can arise.    
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Figure 1.3 – ATP is enzymatically hydrolysed to ADP, AMP and adenosine. P2R (P2Y and P2X) bind 
to ATP and ADP whereas P1R (A1, A2A, A2B and A3) bind to adenosine. The metabolism of 
extracellular ATP is regulated by several ectonucleotidases, including members of the ENTPDase 
(ectonucleoside triphosphate diphosphohydrolase) and the E-NPP (ectonucleotide 
pyrophosphatase/phosphodiesterase) families. Ecto-5’-nucleotidase (Ecto-5’- NT) and alkaline 
phosphatase (AP) catalyse the nucleotide degradation into adenosine. Adapted from Fields & 
Burnstock (2006) and Abbracchio et al. (2009). 
 
 
1.3.1 Purinergic receptors  
1.3.1.1 P2 (ATP) receptors  
In the 1990s, Abbracchio & Burnstock (1994) coined the current nomenclature of 
purinoceptors - metabotropic P2Y (P2YR) and ionotropic P2X (P2XR) receptors. G-protein-
coupled P2YR induce Ca2+ release from intracellular store compartments through PLC/IP3 
pathway. P2XR are cationic ligand-gated nonspecific channels that once activated allow 
the entrance of Ca2+ from the extracelular milieu and also the inward Na+ current, which 
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depolarizes cell membrane and opens voltage-gated Ca2+ channels (Fields & Burnstock, 
2006). 
P2YR comprise two subgroups, P2Y1,2,4,6,11 and P2Y12,13,14, based on their phylogenetic 
similarity and G protein preference (Figure 1.3). The first group corresponds to the group 
described in the previous paragraph and mediates Ca2+ release from the endoplasmic 
reticulum via Gq/G11 proteins. The second group almost exclusively couples to Gi/o 
proteins, which inhibits adenylate cyclase (AC) and modulates ion channels (Abbracchio et 
al., 2009). Concerning P2XR, seven receptor subtypes were identified (P2X1-7), but P2X7R 
seem to contribute more for Ca2+ entry. This receptor is activated at high ATP 
concentrations (100-1000 μM) while the others are activated at lower ATP concentrations 
(1-10 μM) (Abbracchio et al., 2009). As P2X7R are activated at extremely high ATP levels, it 
seems probable that they are associated with astroglial responses to brain lesions 
(Abbracchio et al., 2009). 
Currently, several P2YR (P1Y1,2,4,6,12,13,14) and P2XR (P2X1-7) subtypes have already been 
identified by western blot and immunocytochemistry, in primary rat cortical astrocytes 
(Fumagalli et al., 2003; Fischer et al., 2009). In astrocytes, the P2Y1R and P2X7R seem to 
play a major role in Ca2+ signalling and Ca2+ wave propagation (Fumagalli et al., 2003; 
Fischer et al., 2009). 
 
 
1.3.1.2 P1 (ADO) receptors 
There are 4 types of G-protein-coupled P1 receptors (GCPR): A1, A2A, A2B and A3 (Figure 
1.3) (reviewed by Sebastião & Ribeiro (2009a)). All the receptors are present both in 
neurons and glial cells. High affinity A1 (A1R) and A2A (A2AR) receptors are probably the 
most important both in physiology and pathology. Low affinity A2B (A2BR) and high affinity 
A3 (A3R) receptors are present in low density in most tissues. A1R are widely present in the 
central nervous system, namely in the cerebral cortex, cerebellum and hippocampus. A2AR 
are mainly present in the striatum, nucleus accumbens and olfactory bulb (Ribeiro et al., 
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2003). It was also documented that A2AR are present in other brain areas although in 
lower levels when compared to the striatum (Sebastião & Ribeiro, 1996). A3R are 
moderately present in the cerebellum and hippocampus and in lower density in the rest 
of the brain (Ribeiro et al., 2003).    
Remarkably, adenosine can mediate opposite effects, stimulating via A2AR and A2BR and 
inhibiting via A1R and A3R (Fredholm et al., 2001). A2R are positively coupled to adenylyl 
cyclase (AC) through ‘stimulatory’ Gs-proteins, increasing cyclic AMP (cAMP) levels and 
activating PKA, which stimulates gliotransmitter release (Nishizaki, 2004). A1R and A3R are 
negatively coupled to AC (Peakman & Hill, 1996) through ‘inhibitory’ Gi/o-proteins,  and 
probably inhibit gliotransmission. 
A1R and A2AR subtypes are those that are most likely activated by physiological adenosine 
levels. All adenosine receptors (ADOR) subtypes are known to be present in astrocytes. 
Again A1R are highly present and A2R and A3R are present in lower quantities and 
therefore are difficult to detect (Fields & Burnstock, 2006). 
 
 
1.3.2 ATP, key signalling molecule 
ATP is no longer seen as a mere intracellular energy source, it is now seen as a dominant 
extracellular signalling molecule (Khakh & Burnstock, 2009). After the initial skepticism 
that such a ubiquitous molecule could perform such a specific role, it was shown that ATP 
acts as a neurotransmitter, neuromodulator and co-modulator (Abbracchio et al., 2009). It 
is released and recognized by membrane receptors, both by neurons and astrocytes, in 
physiological and pathological conditions. ATP is also a key messenger of intercellular 
communication, enabling glia to detect neuronal activity and communicate to other glial 
cells by ATP release (Scemes & Giaume, 2006). 
An apparent universal property of astrocytes throughout the central nervous system is 
their responsiveness to ATP. This purine, which is released and co-released along with 
other neurotransmitters from synaptic vesicles, triggers Ca2+ signalling that is the 
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substrate for astrocytic excitability and intercellular communication (Neary et al., 1988; 
Pearce et al., 1989). In addition, astrocytes store ATP in vesicles and release it in a 
regulated-way in response to Ca2+ signalling (Coco et al., 2003).  
Apart from signalling to neurons, astrocytic released ATP, also signals to other glial cells. 
ATP was demonstrated to mediate Ca2+ wave propagation throughout the glial syncytium 
via P2R (Guthrie et al., 1999). Initially, gap-junction communication was seen as the sole 
responsible for wave propagation, allowing direct transference of IP3 and Ca
2+ between 
adjacent cells (Sáez et al., 1989; Finkbeiner, 1992 ; Venance et al., 1997). Then ATP was 
shown to act as a diffusible sign that is recognized by membrane receptors in nearby cells, 
actively participating in Ca2+ wave spreading (Hassinger et al., 1996).   
ATP activates P2R, which then induce further release of ATP, initiating a positive-feedback 
mechanism that is the basis of Ca2+ waves (Scemes & Giaume, 2006). This mechanism 
allows glia to detect synaptic activity, propagating synaptic information through the 
complex web of glial cells, and finally influencing neuronal function at remote sites 
(Halassa et al., 2006).  
In astrocytes, prolonged ATP stimulus (≥ 20 seconds) induces a biphasic Ca2+ response 
consisting of an initial peak followed by a sustained plateau. The transient component is 
evoked by metabotropic P2YR activation and consequent release of Ca2+ from the 
endoplasmic reticulum. The sustained phase is mediated by ionotropic P2XR activation 
and consequent Ca2+ entry from the extracellular medium (Nobile et al., 2003 ; Alloisio et 
al., 2004).  
Unlike classic neurotransmitters, ATP is not removed from the synaptic cleaf. It is 
enzymatically hydrolyzed to ADP, AMP and finally adenosine by ectonucleotidases. 
Therefore it plays a dual role because it can directly activates P2R and, after its 
breakdown into ADP and adenosine, further activates P2R and P1R, respectively, 
prolonging ATP action (Fields & Burnstock, 2006). The potential for ATP to be sustained at 
low levels in the pericellular space is also very important, allowing temporal coding of ATP 
elevation into astrocytic Ca2+ signals.   
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1.3.3 Adenosine, ubiquitous modulator  
Adenosine is a ubiquitous modulator and its receptors are present in both neuronal and 
glial cells throughout the brain. It is not a neurotransmitter since it is neither stored in 
vesicles nor released as classical neurotransmitters (Sebastião & Ribeiro, 2000). However, 
adenosine modulates brain functioning, acting as modulator of modulators (e.g. ATP) 
(Sebastião & Ribeiro, 2009a). This purine controls synaptic activity by acting 
independently on the three levels of tripartite synapses. Presynaptically, regulating 
neurotransmitter release, postsynaplically, modulating neurotransmitter actions, and 
perisynaptically, affecting neurotransmitter uptake and release from astrocytes (Nishizaki 
et al., 2002; Sebastião & Ribeiro, 2009a; Cristóvão-Ferreira et al., 2011).  
This purine is produced intra- and extracellularly by ectoenzymes. Intracellular generated 
adenosine is released via specific bi-directional nucleoside transporters that tend to even 
adenosine levels across the cellular membrane (Fredholm et al., 2001). Extracellular 
conversion of released adenine nucleotides into adenosine through a series of 
ectoenzymes is also an important mechanism as referred earlier (see Figure 1.3).  
Adenosine exerts a dual control upon neuronal excitation and synaptic transmission via 
inhibitory-A1 and excitatory-A2A receptors, which initially puzzled the scientific 
community. The potential for a dual-modulatory action of adenosine was first reported by 
chance by Ginsborg & Hirst (1971; 1972) using a single synapse model in the 
neuromuscular junction. They intended to evaluate the relation between cAMP and 
neurotransmitter release, using adenosine as a pharmacological tool to increase cAMP 
and NT release but surprisingly adenosine decreased NT release.   
Now, adenosine is seen as a complex modulator, rich in shades of regulation that involve 
cooperation of adenosine receptors and other neurotransmitter receptors (Sebastião & 
Ribeiro, 2000; Sebastião & Ribeiro, 2009b). More interesting is that both A1R and A2AR are 
co-localized in nerve terminals (Correia-de-Sá et al., 1991), exerting a balanced 
inhibitory/excitatory modulation over synaptic activity, which seems to depend on 
extracellular adenosine levels. At low concentrations, adenosine acts mostly on high 
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affinity A1R (Fredholm et al., 2001). On the contrary, at slightly higher levels adenosine 
acts predominantly on A2AR (Correia-de-Sá & Ribeiro, 1996). Moreover, cooperation 
among adenosine receptors leads to a direct modulation of the effects mediated by the 
other adenosine receptors, e.g., A2AR activation attenuates A1R mediated inhibition and 
vice-versa (Sebastião & Ribeiro, 2000). Position cooperativity between A1 and A2A 
receptors also occur, namely, in astrocytes (Cristóvão-Ferreira et al., 2011) an issue that 
will be addressed in later sections of the Introduction.    
 
In glial cells, adenosine dual modulation role was first proposed by van Calker et al. 
(1979), who showed that adenosine modulates cAMP accumulation differently, via 
distinct receptors. These authors proposed that A1R mediate the inhibitory effect and A2R 
the facilitatory effect. Later, Porter and McCarthy (1995) documented that adenosine also 
induces increases in astrocytic [Ca2+]i. Around the same time it was shown that adenosine-
elicited Ca2+ responses in acutely isolated cortical astrocytes were mediated via A2BR 
(Pilitsis & Kimelberg, 1998).  
Through astrocytes, adenosine, indirectly modulates the neuronal network. This purine 
modulates gliotransmission thought A1R and A2R, controlling the release and uptake of 
signalling molecules, such as, glutamate (Nishizaki et al., 2002) and GABA (Cristóvão-
Ferreira et al., 2011). 
As adenosine receptors exert a fine modulation over a broad range of neurotransmitters, 
gliotransmitters and modulators, abrupt variation of extracellular adenosine levels might 
interfere in neuronal activity and synaptic transmission, possibly leading to pathological 
situations (Ribeiro et al., 2003).  
 
 
1.3.3.1 Ca2+ signalling modulation by adenosine  
Adenosine is frequently designated as a neuromodulator, but recent evidences indicate 
that this purine is a more general modulator, as Ca2+ excitation in astrocytes is also a 
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modulation target. As a product of ATP hydrolysis by ectoenzymes, adenosine is rapidly 
formed in the extracellular space when ATP is released (≈ 200 msec) (Dunwiddie et al., 
1997). Thus adenosine and ATP co-exist in the extracellular medium for a brief period of 
time. It is, therefore, plausible that adenosine, as a ubiquitous modulator, regulates ATP-
triggered Ca2+ signalling events, a hypothesis that prompted the present work. In addition, 
P2Y1R and A1R are co-localized and present a functional cross-talk in glutamatergic 
synapses and astrocytes (Tonazzini et al., 2007). These receptors can further heteromerize 
(Yoshioka et al., 2002), which represents an intimate cross-talk between nucleotide and 
nucleoside receptors. P2Y2R can also form herero-oligomers with A1R in various regions of 
the rat brain (Namba et al., 2010).   
A1R were shown to potentiate astrocytic Ca
2+ responses induced by metabotropic 
glutamate receptor (mGlutR) activation, a process that involves Gi/o proteins (Ogata et al., 
1994; Toms & Roberts, 1999; Cormier et al., 2001) and potentiation of cAMP levels, which 
depends on A1/A2A receptor cooperation (Ogata et al., 1996). A similar modulatory role of 
adenosine, via A1R, was observed in Ca
2+ signalling induced by muscarinic acetylcoline 
receptors activation (Ferroni et al., 2002).  
ATP-mediated Ca2+ signalling is potentiated by adenosine, via A2BR, in the cortex (Alloisio 
et al., 2004) and the cerebellum (Jiménez et al., 1999), which implies Gs-protein activation 
and consequent rise of cAMP levels. Several studies also demonstrated that adenosine 
modulates Ca2+ response triggered by ATP in other cell models, namely, cell lines (Gerwins 
& Fredholm, 1992; Fredholm et al., 2003), tracheal smooth-muscle cells (Michoud et al., 
1999) and rat thyroid FRTL-5 cells (Vainio & Tornquist, 2000). 
Alloisio et al. (2004) reported a differential modulatory role of A1R and A2BR on biphasic 
Ca2+ transients (see section 1.3.2). A2BR activation potentiates the initial Ca
2+ peak and A1R 
activation downregulates the sustained response. No information was reported about the 
possible dual-modulatory role of adenosine receptors upon the initial transient Ca2+ peak, 
an issue that is included in the scope of this project. 
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1.3.3.2 Cooperation between ADOR 
The presence of overlapping tissue distribution of adenosine receptors raises questions 
about the functional significance of their co-localization and most importantly the 
possible interactions between these receptors (Fredholm et al., 2011). This is of particular 
importance because adenosine mediates both inhibitory and excitatory effects through 
A1R and A2AR, respectively. 
Evidences have been accumulated for functional cross-antagonism interactions between 
A1R and A2AR in glutamate release modulation in the striatum and hippocampus (O'Kane 
& Stone, 1998; Lopes et al., 2002). A1R and A2AR homomers were detected both in HEK293 
and CHO transfected cells (Fredholm et al., 2011). In addition, the co-localization and 
heterodimerization of A1R-A2AR was demonstrated in co-transfected HEK cells and striatal 
glutamatergic nerve terminals (Ciruela et al., 2006). Moreover, this heteromers regulate 
differential glutamate release from presynaptic nerve terminals via A1R and A2AR. This 
modulation seems to depend on synaptic adenosine levels, working as a “concentration-
dependent switch”, which fine-tunes modulation of striatal glutamatergic 
neurotransmission. 
In non-transfected primary cortical astrocytes,  A1R and A2AR were shown to cooperate in 
GABA uptake modulation (Cristóvão-Ferreira et al., 2011). Moreover, these receptors are 
physically linked in the cellular membrane as a heterotetramer - A1R- A1R-A2AR-A2AR. On 
the one hand, the A1R homodimer mediates inhibition of GABA transport and, on the 
other hand, the A2AR homodimer facilitates its transport. Each homodimer is coupled to 
the respective Gi/o or Gs-protein and both proteins have to be activated in order for the 
modulation to occur. A1R-A2AR differential activation also depends on extracellular 
adenosine concentration, resulting in differential GABA uptake modulation under distinct 
physiological situations. At relatively low adenosine levels A1R are preferentially activated 
and as adenosine levels rise, A2AR activation overcomes the previous one and A1R affinity 
for agonist is decreased.    
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2 Aims 
Adenosine is a potent neuromodulator, acting directly onto neurons, but now we are 
unveiling indirect neuromodulation via astrocytes. Although evidences indicate that 
adenosine modulates Ca2+ signalling triggered by neurotransmitters, namely ATP, it is not 
clear what is/are the adenosine receptor(s) with a preponderant role in this modulation. 
In addition, A1R and A2AR cooperate in GABA uptake modulation in cortical astrocytes. 
Nonetheless, nothing is known about a possible similar cooperation mechanism between 
adenosine receptors to modulate Ca2+ signalling and consequent gliotransmitter release. 
Overall, the aims of this project were to evaluate the role of adenosine receptors, mainly 
A2AR, in ATP-induced Ca
2+ signaling and to explore the possible cross-talk between A1R and 
A2AR in this modulation.  
 
The specific aims of this work were: 
1. To develop and optimize a Ca2+ imaging protocol to study Ca2+ response modulation 
by adenosine; 
2. To characterize the adenosine receptors involved in the modulation of Ca2+ responses 
in cortical astrocytes; 
3. To study if cooperation and/or interaction between high affinity adenosine receptors, 
primarily A1R and A2AR, is required or not for the modulation effect; 
4. To characterize cortical astrocytic primary cultures by,  
4.1 Quantifying different cell populations, namely astrocytes, neurons and microglial 
cells and; 
4.2 Demonstrating the presence of ATP (P2Y1R) and adenosine (A1R and A2AR) 
receptors. 
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3 Methods 
3.1 Primary enriched-astrocytic cultures 
Cortical astrocytes were obtained from 0-2 days old (P0-P2) Wistar pups, purchased from 
Harlan Interfauna Iberia (Barcelona, Spain). The procedure was carried out as previously 
described by Cristóvão-Ferreira et al. (2011). Animals were handled according to the 
Portuguese law on Animal Care and European Union guidelines (86/609/EEC). 
Pups were killed by decapitation and the heads were sterilized by sequential submersion 
on alcohol. Inside the laminar flow, heads were transferred to a phosphate buffered saline 
(PBS) solution (in mM: 137 NaCl; 2.11 KCl, 1.8 KH2PO4; 10 NaH2PO4, pH 7.4), where they 
were dissected. After opening the skin and skull, the brain was detached, the cerebellum 
was removed and the two hemispheres of the brain were separated. With the help of a 
dissecting microscope, the white matter, hippocampus and meninges were removed and 
then the cortex was mechanically dissociated, with a 10 mL pipette, in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Gibco/Invitrogen®) supplemented with 2mM 
glutamine, 10% (v/v) fetal bovine serum (FBS) (both from Gibco®) and 
Antibiotic/Antimicotic solution (100 U/mL penicillin, 0.25 μg/mL anphotericin B and 100 
μg/mL streptomycin) (Sigma®). Then followed two filtrations, firstly with a 230μm pore 
and secondly with a 70μm pore. After each filtration cells were centrifuged at 200g for 10 
minutes, the supernatant was discarded and the pellet was resuspended in 10 mL of 
DMEM supplemented medium. After the last centrifugation the pellet was resuspended 
for the final volume of 10 mL of DMEM supplemented medium for each cortex. Cells were 
plated in T-75 (75 cm2) culture flasks, for Ca2+ imaging and immunocytochemistry, or in 
100-mm-diameter petri dishes, for western blot. Cells were plated at a density of 38x104 
cells/mL (n = 4 independent cultures). Cultures were maintained in a humidified incubator 
with 5% CO2 at 37
oC. Cell counting was performed in 75% trypan blue cellular solution 
using a hemacytometer.  
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After 6 days in culture (DIC 6), cells in the T-75 culture flasks were shaken for 4-5h at 37oC, 
the supernatant was removed and DMEM supplemented medium was added. At DIC 7, 
the T-75 culture flasks were shaken again for 2-3 hours at 37oC, the supernatant 
containing mostly microglia was removed and then cells were washed once with PBS. The 
adherent astrocytes were enzymatically dispersed (trypsin-EDTA 0.025%) under agitation 
1-2 minutes at 37 oC. The enzymatic reaction was stopped by adding excess of DMEM 
supplemented medium. Cells were diluted in DMEM supplemented medium (1:7) and 
seeded over γ-irradiated glass bottom microwell dishes (glass thickness: 0.16-0.19mm, 
glass diameter: 14mm, MatTek®) for imaging experiments or over glass coverslips placed 
in 24-well plates for immunocytochemistry. Glass coverslips were previously incubated 
with poli-L-lysine (0,01 mg/mL) for 1 hour and afterwards washed with sterile water, to 
improve cell adhesion. For Ca2+ imaging experiments, cells were used from DIC 9 to DIC 
14, similar to what was previously described by Alloisio et al. (2004) (DIC 10-15). 
The shaking procedure was applied to obtain cultures with a higher percentage of 
astrocytes in relation to other cell populations, namely microglial cells. The latter cells 
grow upon astrocytes and for this reason are easy to detached and discard with the 
supernatant (Jiménez et al., 1999; Du et al., 2010). 
 
 
3.2 Ca2+  Imaging experiments 
3.2.1 Technical Approach 
The development of optical probes and non-invasive methods to study the dynamics of 
intracellular ions in living cells provided the technological tools to further explore 
astrocyte functions, unveiling their Ca2+ excitable mechanism. The Ca2+ imaging technique 
allows to follow variations of free Ca2+ ions in the cytoplasmic and organellar 
compartments, using sensitive Ca2+ probes to define spatial and temporal patterns of Ca2+ 
behavior.      
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3.2.1.1 Ca2+  indicators 
Ca2+ sensitive probes are molecules from the family of BAPTA (1,2-bis(o-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), a relative of the ion chelator – EGTA 
(Ethyleneglycol bis(β-aminoethylester)-N,N,N’,N’-tetraacetate), which bind selectively to 
free Ca2+ ions, forming reversible complexes. These sensors are fluorochromes that 
undergo a conformational change and consequently a variation in its fluorescence 
properties when bounded to Ca2+. The most common differences are in the excitation 
and/or emission of light (Rudolf et al., 2003).  
The first fluorescence Ca2+ probe for intracellular use was sintetized by Roger Tsien and 
collaborators in the late 1970s (Tsien, 1980). Currently, several indicators are available 
with different dissociation constants (Kd), which corresponds to different affinities for Ca
2+ 
ions. Therefore, when accessing Ca2+, the probe should be compatible with the [Ca2+]i 
range of interest. Higher [Ca2+]i require a probe with smaller affinity, which means a 
higher Kd (Paredes et al., 2008).   
There are two main groups of Ca2+ sensitive dyes: 
 
Non-ratiometric dyes 
These are single-wavelength fluorophores, which allow determining relative [Ca2+]i by 
relative increase in the fluorescence intensity. There is no shift in excitation or emission 
wavelength. Disadvantages are susceptibility to variations in dye concentration, 
photobleaching or leakage from the cell (Johnson & Spence, 2010).  
  
Ratiometric dyes 
These fluorochromes do not measure [Ca2+]i directly, instead the indicator monitors the 
amount of free and complexed probe. There are two subgroups of ratiometric dyes: dual 
emission and dual excitation, as the emission or excitation wavelength varies in the 
bounded/unbounded forms. [Ca2+]i is determined by the ratio of fluorescence emission or 
excitation at distinct wavelengths (Johnson & Spence, 2010).  
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Fura-2, which was used in this project, is the most widely used ratiometric probe and was 
firstly synthesized in the 1980s by Tsien’s group (Grynkiewicz et al., 1985). Its absorbance 
peak shifts from 380 nm (F380) in the Ca2+-free state to 340 nm (F340) in the Ca2+-
bounded state (Figure 3.1). The emission wavelength is maintained at 510 nm. In this 
case, the F340/F380 fluorescence ratio is used to access variations in [Ca2+]i.     
In addition, ratiometric dyes present a series of advantages as they allow correcting for 
uneven dye loading, dye leakage, photobleaching, dye concentration and changes in cell 
volume. Furthermore, measurements with these dyes can be performed over a period of 
one hour without significant loss of fluorescence (Johnson & Spence, 2010). 
 
340 nm
380 nm
 
Figure 3.1 – Fluorescence excitation spectra of Fura-2 in solutions containing increasing levels of 
free Ca
2+
 (0-39.8 μM). 380 nm – maximum fluorescence emission in Ca
2+
-free medium; 340 nm – 
maximum fluorescence emission in Ca
2+
-saturated medium. Image from Johnson & Spence (2010).    
 
The fluorochrome used here, Fura-2, has affinity for Ca2+ (Kd) of approximately 224 nM 
(Grynkiewicz et al., 1985), which means that, theoretically, it is suitable for measuring 
[Ca2+]i between 22.4 nM - 2240 nM (0.1* Kd – 10* Kd) (Paredes et al., 2008). In practice, 
Fura-2 is generally used to detect [Ca2+]i below 1 μM.  
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The bulk Ca2+ baseline level for all the primary astrocytes studied here was estimated to 
be approximately 93.05 ± 5.60 nM (n = 247 cells from 62 independent experiments). This 
value is consistent with the normal cytosolic Ca2+ levels ≈ 100 nM (Knot et al., 2005; 
Barhoumi et al., 2010). Furthermore, the amplitude of Ca2+ transients (Δ[Ca2+]i) presented 
here goes up to a maximum of about 500 nM. Therefore, the interval of [Ca2+]i evaluated 
in the present work was below 1 μM and for this reason, Fura-2 is appropriate to detect 
this interval of [Ca2+]i.  
If saturating [Ca2+]i levels were reached for Fura-2 ([Ca
2+]i > 1 μM), the fluorophore loses 
its capacity to accurately report ion concentration. In this case, another indicator would 
have to be chosen, such as, Mag-FURA-2 that has a higher Kd value (25 μM). This 
fluorochrome avoids early saturation due to its low Ca2+ binding affinity and therefore it 
can be used to detect a range of higher [Ca2+]i (1-100 μM). Mag-FURA-2 is also a 
ratiometric dye and presents excitation and emission wavelengths similar to FURA-2, 
which makes it appropriate to substitute our dye. 
 
Cell loading can be achieved through several different techniques, such as, microinjection, 
diffusion from patch clamp pipettes, electroporation, hypoosmotic shock and, the non 
invasive, AM ester loading (Paredes et al., 2008). The latter technique, was firstly 
described in the 1980s (Tsien, 1981) and depends on acetoxymethyl esters (AM) groups 
that are part of the fluorophore molecule and confer a general neutral charge, allowing 
passive diffusion across the cellular membrane. Once inside, the AM groups are cleaved 
by cellular enzymes – esterases – so the fluorochrome becomes charged and is trapped 
inside the cell. This loading technique is simple, requires no previous expertise and is 
highly effective. Moreover, it allows the simultaneous loading of an entire population of 
cells. For all the reasons presented above, Fura-2AM was the Ca2+ indicator of choice.    
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3.2.1.2 Experimental apparatus 
In this project, it was used a high intensity light source, xenon arc lamp, which emits 
uniformly across the entire UV spectrum. A set of specific excitation interference filters 
(340 nm and 380 nm), with a band-pass filter system, select the appropriate wavelength 
(Figure 3.2). Follows a dichroic mirror that produces a light cone to focus excitation light 
into the preparation.   
As astrocytes, during experiments, were alternately irradiated at two UV wavelengths 
(340 and 380 nm), it is important to alternate irradiation as fast as possible. For that, the 
irradiation time at each wavelength was decreased to the minimum so that one can 
obtain more values and therefore gain sensitivity to detect the maximum of the peak. 100 
ms is the minimum technically possible and therefore the light source was programmed 
for this duration.  
 
Detector
CCD camera (510 nm)
Ocular
> 450 nm
Emission filter
480<   <530 nm
Band-pass excitation filter
(≈ 340 or ≈380 nm)
Cell culture
Xenon arc 
lamp
Objective
Wavelength selector
Dichroic mirror
 
Figure 3.2 – Light path in an inverted epifluorescence microscope.  
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To image cultured cells, an inverted epifluorescence microscope was used, where the 
excitation light passes from below, through the objective lens and onto the cells. The light 
emitted by cells, at a higher wavelength, goes to the detector in the lower part of the 
apparatus (Figure 3.2).  
An additional dichroic mirror followed by an emission filter is used, between the objective 
and the detector, to filter the fluorescent light, selecting the emission wavelength of the 
emitted light that goes into the detector. The detector is a CCD camera, which rapidly 
integrates data, enabling several measurements per second (Figure 3.2).   
 
3.2.2 Ca2+  experiments 
Fluorescence measurements were performed by Ca2+ imaging technique, at room 
temperature (RT) (22 oC), using the fluorescent Ca2+ dye, Fura-2AM. Prior to each 
experiment, cells were incubated with 5 μM Fura-2AM in HEPES buffer (in mM: 125 NaCl; 
3 KCl; 1.25 NaH2PO4; 10 glucose; 10 HEPES; 2 CaCl; 2 MgSO4; pH ~ 7.38) (Rose et al., 
2003) for 45 minutes at 37 oC. Previously and after fluorochrome incubation, cells were 
gently washed with HEPPES buffer (2-3x). The glass bottom microwell dish (glass 
thickness: 0.16-0.19mm, glass diameter: 14mm, MatTek®) was placed on the stage of an 
inverted epifluorescence microscope (Axiovert 135TV, Zeiss®) with a 60x objective, 
equipped with a high speed multiple excitation fluorimetric system (Lambda DG-4, Sutter 
Instruments®, with a 175W Xenon arc lamp). Data was recorded by a CCD camera 
(Photometrics® CoolSNAP fx). The perfusion medium was activated using a rotating pump 
system (Mini PULS3, GILSON®) and cells were left for temperature stabilization for about 
15 minutes in the beginning of each experiment. This stabilization period also assures 
complete de-esterification of the dye. Cell cultures were continuously perfused 
throughout experiments with HEPES buffer at a rate of approximately 1.5mL/minute. This 
rapid flow prevents the accumulation of ATP, adenosine or any other compound secreted 
by cells (Jiménez et al., 1999). Special care was taken regarding the volume of buffer in 
the perfusion chamber. It is of utmost importance that the volume is maintained constant 
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during the entire experiment because slight variations influence enormously the signal 
response.  
Stimulation by 10 μM ATP, for 200 miliseconds, was achieved through a glass electrode 
(1.5 mm OD x 0.86 mm ID, Harvard Apparatus®) coupled to a micromanipulator 
(InjectMan® IN2) and a pressurized system (injection pressure of 15 psi) (FemtoJet®, 
Eppendorf®). Once an optimal position of the glass electrode was defined in the beginning 
of the experiment, it was very important to maintain it invariable throughout the 
experiment, since variations in its position affect enormously cellular response. This was 
achieved by holding the glass electrode firmly with a micromanipulator.  
Drug treatment was applied through the perfusion medium, for at least 15-20 minutes, 
followed by a washout period with HEPES buffer or further treatment with a drug mixture. 
Exchange between perfusion mediums was efficiently achieved with a semi-automatic tap 
system in a fast, non-destabilizing manner.  
Fura-2 AM loaded astrocytes were continuously and sequentially excited both at 340nm 
and 380nm, for 100 ms at each wavelength, and the emission fluorescence was recorded 
at 510nm. Background fluorescence and autofluorescence were automatically subtracted 
by the MetaFluor® software. The software also calculated and reported, in real-time, the 
fluorescence ratio F340/F380 and this parameter was used to monitor [Ca2+]i changes. The 
calculus to convert fluorescence ratio into [Ca2+]i are presented below (see section 3.2.4).  
Experiments were performed on cells with a baseline fluorescence ratio around 2, which 
corresponds approximately to a [Ca2+]i of about 100 nM, the normal [Ca
2+]i (Knot et al., 
2005; Barhoumi et al., 2010). Cells with a baseline fluorescence ratio above 3 were 
discarded for experiment. 
 
3.2.2.1 Drugs 
Drug concentration was chosen so that it acts selectively in the target receptor and does 
not desensitize it (Table 3.1), similar to drug concentration previously used by Cristóvão-
Ferreira et al. (2011).  
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Table 3.1 – Drugs used in Ca
2+
 imaging experiments, the effect they mediate and respective 
concentrations.  
Drug Mediated effect Concentration (nM) Brand 
CADO blanket  ADOR  agonist 1000 C-5134 – SIGMA® 
CGS 21680 A2AR agonist 30 1063 – Tocris® 
SCH 58261 A2AR antagonist 50 2270 – Tocris® 
DPCPX A1R antagonist 50 0439 – Tocris® 
 
CADO has a dissociation constant (Kd) of 9.3 nM for A1R and of 63 nM for A2AR (Fredholm 
et al., 2001). The selectivity ratio for the two receptors is lower than 10 and for this 
reason CADO is considered and used as a non-selective adenosine receptor agonist. On 
the contrary, CGS 21680 has a Kd of 22 nM for A2AR and the Kd for A1R is higher than 1 μM, 
being, therefore, considered as an A2AR selective agonist (Fredholm et al., 2001). Similarly, 
SCH 58216 has a Kd of 2.3 for A2AR and 120 nM for A1R and, therefore, is considered as an 
A2AR selective antagonist. On the contrary, DPCPX has a Kd of 0.3 for A1R and 340 nM for 
A2AR and, therefore, is considered as an A1R selective antagonist (Fredholm et al., 2001).  
The drug application and incubation period are also fundamental in pharmacological 
studies. Drugs were applied through the perfusion medium for at least 15-20 minutes. The 
incubation time is important to allow drug binding to receptors and the detection of its 
effect. In some experiments, this time was prolonged because the effect onset varied 
from cell to cell. Other authors described topical and brief drug application, 
simultaneously to the ATP stimulus (Alloisio et al., 2004), or a brief 3 minute incubation 
(Jiménez et al., 1999). This short period of incubation might not lead to total activation of 
selective receptors. 
 
3.2.3 Recording and analysis of Ca2+  transients  
For the recording of Ca2+ transients, a specific cell was chosen from the culture and it was 
pressure stimulated with 10 μM ATP (200 ms) every 5 minutes throughout the experiment 
(Figure 3.3). Its response, as well as, the responses of surrounding cells were recorded for 
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about 40 seconds every 5 minutes (see Figure 3.3). The stimulus was applied 10 seconds 
after the beginning of the recording and the transient lasted for about 20 seconds, varying 
from cell to cell, until the Ca2+ basal levels were reached again. Preferentially, cells should 
be irradiated for the shortest period possible (≈ 40 seconds) to prevent fluorescence 
bleaching, since the experiments are long and they are irradiated several times 
throughout the experiment.  
The initial idea was to work on single-cell experiments, because the response observed in 
surrounding cells might be affected by the propagation of the Ca2+ wave and not only by 
the test drug itself. Nevertheless, when results were analyzed, considering whether the 
cell had been directly stimulated or not, it was concluded that responses from cells that 
were close to the stimulated cell do not differ from the latter. For this reason, results 
presented here take into account not only the stimulated cell (depicted with a red circle, 
Figure 3.3) but also those cells that were directly surrounding the stimulated cell 
(depicted with blue and green circles, Figure 3.3), since they seem to have responded by 
direct ATP stimulation. 
 
(a) (b)
 
Figure 3.3 – Representative images of a Ca
2+
 imaging experiment. (a) Fluorescence image of 
primary astrocytes (excitation 340nm, emission 510nm) – schematic representation of a glass 
electrode. The circles represent the regions of interest (ROI). (b) Image representing F340/F380 
ratio, where the color scale corresponds to fluorescence ratio (F340/F380), allowing to evaluate 
variations in [Ca
2+
]i.  
                     Methods 
 
 
33 
 
Initially, HEPES buffer was applied in the perfusion medium and cell response to 10 μM 
ATP (200 ms) was recorded in the absence of drugs (Figure 3.4). After the first three or 
four ATP stimuli, when the cellular response was fairly stable, the perfusion medium was 
changed for the test drug diluted in HEPES buffer and cell response was recorded for at 
least 15-20 minutes. After this period, the medium was changed again for HEPES buffer, 
for washout, or for the appropriate drug mixture and cell response was recorded again for 
at least 15-20 minutes. In few individual cases this period had to be extended, specifically 
with CGS 21680, an A2AR selective agonist, because it is difficult to washout due to its 
lipofilic characteristics. At the end of every experiment, maintaining the previous 
perfusion medium (HEPES buffer or test drug mixture), the maximal cellular response was 
recorded applying a maximal stimulus with 100 μM ATP (200 ms).  
 
0 10 30 50 60 minutes
HEPES buffer Test Drug HEPES buffer (drug washout) 
or any other drug plus test drug
Test drugs in 
the perfusion medium
10 μM ATP (200 msec) 100 μM ATP (200 msec)
ATP Stimulus every 5 minutes
20 40
Pressure-application of ATP
 
 
Figure 3.4 – Timeline for stimulation and drug application of a typical Ca
2+
 experiment. Each arrow 
corresponds to a stimulus, applied every 5 minutes. Above are presented the ATP concentrations 
values used as stimulus and below are the solutions applied through the perfusion medium.   
 
In very few experiments, particularly those where an agonist and an antagonist of the 
ADOR were applied together to revert agonist action, cell response to 100 μM ATP was 
not increased in comparison to 10 μM ATP. In these cases, cells were submitted to a 20 
minute washout with HEPES buffer, as they continued to be stimulated with 10 μM ATP 
every 5 minutes. After this period, cells were stimulated again with 100 μM ATP and 
response amplitude was considered as maximal. This protocol was not applied to all 
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experiments, because it was observed that in most cases the maximal cell response 
previously and after this washout period were not markedly different as can be seen in 
Figure 3.5.  
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Figure 3.5 – Representative Ca
2+
 mediated responses to 100 μM ATP (200 ms), previously and after 
the extra 20 minutes washout step with HEPES buffer.   
 
To estimate the amplitude of a Ca2+ transient, the mean of the first ten values (10x200ms) 
recorded before stimulation was calculated and it was taken as the baseline Ca2+ level. 
Then the amplitude was calculated by the difference between the highest value recorded 
for the Ca2+ transient and the baseline Ca2+ level. The amplitude of the control response, 
in the absence of any drug, was considered as the mean amplitude obtained for the 
transients at 5 and 10 minutes (identified in Figure 3.6). Usually, at this point cell response 
was fairly stable but if this was not the case, stimulation was continued, still with HEPES 
buffer in the perfusion medium, until the cell response was stable. Then control response 
was considered as the mean amplitude of the two last transients with HEPES buffer in the 
perfusion medium.  
For the magnitude of drug response it was considered the largest change in the Ca2+ 
transient (maximal effect), which occurred 10 to 25 minutes after the beginning of drug 
perfusion. It was not possible to impose a determined period of time because each cell 
responds differently, therefore some cells would respond rapidly and other would take 
longer to respond to the drug. Some cells did not respond to drugs at all, especially those 
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that already presented considerable large Ca2+ transients in the absence of the drug. Data 
from these cells was also considered to calculate the average. Drug perfusion time could 
not be further increased because after a long experiment, with repeated stimulations, 
there is a tendency for a spontaneous decrease of ATP-induced Ca2+ transients, even in 
the absence of drugs. It was considered as drug response only the amplitude of one 
transient and not the average of two transients because responses were very different in 
amplitude as this parameter was increased by drug effect (see Figure 3.6). 
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Figure 3.6 – Time course of Ca
2+
 response of a typical Ca
2+
 imaging experiment. Ca
2+
 peaks 
represent cell response upon ATP stimulation. All stimulations were performed with 10 μM ATP, 
except for the last one, indicated with an arrow, in which 100 μM ATP was used. 1 μM CADO was 
applied through the perfusion medium.  
 
Concerning the final step to revert drug effect, with HEPES buffer or an agonist/antagonist 
drug mixture, the washout response was taken as the average of the two last transients 
before the maximal stimulus. The amplitude of maximal response was calculated as 
stated previously when cells were stimulated with a supramaximal ATP concentration 
(100 μM).  
 
 
Methods 
 
 
36 
 
3.2.4 Calibration procedure 
[Ca2+]i was calculated from fluorescence ratio (F340/F380) using the classical equation 
developed by Tsien’s group (Equation 3.1) (Grynkiewicz et al., 1985). The Kd is the 
dissociation constant  of Fura-2 AM  to Ca2+, R is the fluorescence ratio (F340/F380) value, 
Rmax is the R value at saturating extracellular [Ca2+] ([Ca2+]free = 2  x 10
-3 M), Rmin is the R 
value at low extracellular [Ca2+] ([Ca2+]free = 4.172 x 10
-9 M), A2 is the fluorescence emitted 
at 510 nm when cells are irradiated at 380 nm at low extracellular [Ca2+] and B2 is the 
fluorescence emitted at 510 nm when cells are irradiated at 380 nm at saturating 
extracellular [Ca2+]. 
 
Equation 3.1                         
 
 
Fura-2 AM, the Ca2+ probe used, has a Kd of 224 nM for a solution with 1 mM of Mg
2+ 
(Grynkiewicz et al., 1985). All the other parameters of the equation were experimentally 
determined using a calibration procedure according to Benech et al. (2000). In these 
experiments cells were not stimulated with ATP, only the basal [Ca2+]i were recorded for 
about 30 seconds, every 5 minutes. 
Firstly, the basal [Ca2+]i were recorded with HEPES buffer in the perfusion medium. The 
average of all the values recorded is the resting Ca2+ level for that specific cell, Rrest (see  
 
Figure 3.7 and Figure 3.8 (a)). Then the perfusion medium was changed for a low-Ca2+ 
HEPES buffer (EGTA 10 mM - in mM: 125 NaCl; 3 KCl; 1.25 NaH2PO4; 10 glucose; 10 
HEPES; 0.5 CaCl; 1.5 MgCl2; 2 MgSO4; 10mM EGTA pH ~ 7.38), which mimics an 
extracellular low-Ca2+ situation ([Ca2+]free = 4.172 x 10
-9 M, at 22oC and pH 7.38, calculated 
using MaxChelator® tool at maxchelator.stanford.edu). Followed by the addition of 1μM 
ionomycin free-acid (Ascent®) to the medium. This ionophore complex with Ca2+ and 
carries it across lipophilic membranes. Here it is responsible for the leak of Ca2+ from the 
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citosol of the cell to the extracellular medium, since the [Ca2+]i is about 100 x 10
-9 M, and 
consequent total depletion of intracellular Ca2+ storages. For this reason the cellular basal 
[Ca2+]i decreases to a minimum, Rmin. This parameter is the average of all values recorded 
during the 30 seconds that cells were irradiated (≈ 5 values are recorded per second). 
Usually, Rmin is reached after the medium transition for regular HEPES buffer with Ca2+, 
right before the basal [Ca2+]i increases (see Figure 3.8 (a)). EGTA should be kept in 
perfusion for the shortest period of time possible because the lack of Ca2+ can lead to cell 
detachment from the glass coverslip. Then the perfusion medium was changed for HEPES 
buffer (still with 1 μM ionomycin). This medium, with Ca2+ ([Ca2+]free = 2  x 10
-3 M), leads to 
an increase in the [Ca2+]i and consequent dye-saturation. The maximal level represents 
Rmax (see Figure 3.8 (a)). Keeping ionomycin present at this point allows the cells to 
reach higher basal [Ca2+]i. 
 
0 10 30 50 60
HEPES buffer Low-Ca2+
HEPES buffer
(10 mM EGTA)
Perfusion
medium
Low-Ca2+ HEPES buffer
(10 mM EGTA)
+
1 μM Ionomycin
20 40 70 minutes
HEPES buffer
+
1 μM Ionomycin
Rrest Rmim Rmax
1mM MnCl2
Recording every 5 minutes
 
 
Figure 3.7 – General scheme of a typical calibration procedure experiment. Each vertical line 
corresponds to the recording of cellular response for 30 seconds. Below are the solutions applied 
through the perfusion medium. Arrows represent the values that were used to calculate Rrest (0-
10 minutes), Rmin (45 minutes) and Rmax (55 minutes).   
 
Once reached the maximal [Ca2+]i, 1mM MnCl2 is added topically and carefully to the 
perfusion chamber with a pipette. MnCl2 extinguishes the fluorescence from the 
fluorochrome leaving only the cellular autofluorescence, Rzero (Figure 3.8 (a)). In most 
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experiments, the values of Rmax and Rmin were very similar because the computer 
software automatically subtracted the background fluorescence and autofluorescence. 
A2 and B2 were determined from the emission fluorescence at 510 nm when cells were 
irradiated at 380 nm, corresponding to the emission of the unbound dye (Figure 3.8 (b2)). 
A2 is the fluorescence emitted when [Ca2+] in the medium is minimal, corresponding to 
Rmin in the fluorescence ratio. B2 is the fluorescence emitted when external [Ca2+] is 
maximal, corresponding to Rmax in the fluorescence ratio.     
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Figure 3.8 – Representative fluorescence of Ca
2+
 mediated responses for a calibration procedure. 
(a) Fluorescence ratio (F340/F380), (b1) fluorescence at 340 nm and (b2) fluorescence at 380 nm. 
Solutions applied through the perfusion medium are indicated. 
 
The calibration protocol to convert fluorescence ratio (F340/F380) into [Ca2+]i should be, 
ideally, performed in the end of each and every experiment, since the parameters 
determined are specific of each cell. However, at the end of long experiments, such as 
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these, cells would respond differently to the protocol compared to their typical response. 
Moreover, not all the drugs used are easily washed out from cells, which would certainly 
affect cell response. For these reasons, it was decided to perform separate experiments, 
in which designated batches of cells were used to apply the calibration procedure. The 
previous parameters were calculated taking into account cell responses from these 
experiments. 
5 independent experiments were performed and each one of the specific parameters 
(Rrest, Rmin, Rmax, A2 and B2) was determined for each cell. Then, from the average of 
the parameters estimated for all the cells of one experiment, the [Ca2+]i was calculated 
using the equation of Grynkiewicz et al. (1985) (Equation 3.1). Then, the values of [Ca2+]i 
vs. mean values of F340/F380 were plotted (Figure 3.9). Appling the equation determined 
by the linear regression of the points ([Ca2+]i = 73.796 x F340/F380 – 26.494), it was 
possible to convert the fluorescence ratio of all the other experiments into [Ca2+]i.  
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Figure 3.9 – Plot of [Ca
2+
]i (nM) vs. mean value of fluorescence ratio (F340/F380) and respective 
linear regression equation. Each value represents the average of the values calculated for cells of 
one experiment. 
 
3.3 Optimization of Ca2+  imaging experiments 
The experimental protocol, to study Ca2+ transient modulation by adenosine, described in 
the previous section was developed and conditions, such as the interval between stimuli, 
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ATP concentration, stimulation length, rate of the perfusion medium and incubation and 
perfusion temperatures were optimized. Experimental approach and conditions, inspired 
in previous works (Jiménez et al., 1999; Alloisio et al., 2004), were improved to fulfill the 
aims of this project.  
 
3.3.1 Interval between stimuli  
The initial idea was to obtain a cellular response for each of the experimental conditions, 
in the absence of drug, in the presence of the test drug and after the washout. In early 
experiments, cells were stimulated with ATP every 20 minutes, which is coincident with 
the minimum period of time for the ADOR ligands to be effective, when applied through 
the perfusion medium. This was the type of approach used by Alloisio et al. (2004) and 
Jimenez et al. (1999). However, obtaining just one response per condition was not a good 
approach due to the slight oscillations in cellular response throughout experiments. This 
variability was observed not only within cell population but also for each cell in particular. 
Therefore, in order to accurately differentiate slight drug effects it was important to 
obtain several measures for each condition so that an average response could be 
estimated. For this reason, it was decided to decrease the interval between stimulations.  
Experiments were performed using 2 minute intervals between stimuli but it seemed that 
the interval was too short. Cells did not have enough time to recover, probably to refill 
the internal Ca2+ storages, and therefore Ca2+ response amplitude decreased throughout 
experiments. 
Subsequently, experiments were performed using 5 minute intervals between stimuli. 
This seemed to be an ideal protocol because it allowed cells to recover from the 
continuous stimulation and also the recording of several cellular responses for each 
condition. However, with this protocol, the length of the experiment increased and cells 
were continuously exposed to UV light. A natural concern was whether cells would 
continue to respond or not. It was experimentally confirmed that cells were able to 
maintain their response for more than one hour.  
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3.3.2 ATP concentration  
It was highly important to determine the ATP concentration to be used as stimulus. To 
study the potential effect, potentiation or inhibition, of drugs on Ca2+ transients it is 
imperative to obtain a response that is significant but that is not maximal.  
For this purpose, cumulative concentration-response experiments were performed. Cells 
were sequentially stimulated with increasing ATP concentrations (in μM: 0.1, 0.5, 1, 5, 10, 
50, 100, 500, 100) every 5 minutes. For each concentration, 2 responses were recorded 
and the average was estimated. For the total pool of cells studied (n=20), 10 μM ATP, 
seems to be a good stimulus because it elicits a significant signal response, compared to 
lower concentrations, nevertheless it does not equals cell maximal response (Figure 3.10 
(a)). Surprisingly, maximal response is observed for 50 μM ATP and it is not overcome for 
higher ATP concentrations. This result could be due to desensitization of ATP receptors to 
higher agonist concentrations. However, an individual analysis of cellular responses 
showed that this was a heterogeneous cell population, in which two different cellular 
behaviors can be distinguished for responses to high ATP concentration stimulation. On 
the one hand, some cells are able to respond to high concentrations and it is seen that a 
plateau is reached for ATP concentrations equal or higher than 50 μM (Figure 3.10 (b1)). 
On the other hand, few cells clearly present a diminished response capacity as the 
concentration of ATP stimulus was increased (Figure 3.10 (b2)). It is noteworthy that the 
latter population of cells presents a higher mean response to 10 μM ATP. From this 
individual analysis, because the decay in cell response is not common to all cells, it can be 
proposed that this effect is not due to receptor desensitization but due to repetitive cell 
stimulation, which leads to progressive lost of response capacity. 
The lost of response capacity is indeed one of the disadvantages of cumulative 
concentration-response studies, where the same target cell is used throughout the 
experiment. Another shortcoming is that results obtained do not correspond to the real 
maximal cell response as cells saturate. Nevertheless, they are a good approach for the 
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present purpose of finding an optimal ATP concentration since we do not have the 
problem of variability in cell response associated to different cells.      
50 μM ATP and higher concentrations are supramaximal, meaning that the cell response 
obtained upon stimulation is maximal. For this reason, 100 μM ATP was used to measure 
the maximal response of each cell to ATP stimulation.  
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Figure 3.10 – Mean amplitude of Ca
2+
 transients upon stimulation with increasing ATP 
concentrations with the fitting of a cumulative Gaussian curve. (a) Total pool of cells studied (R
2
 = 
0.953). (b1), (b2) Cell populations with different responses within the total pool of cells ((b1) R
2
 = 
0.998). Results are presented as mean of n cells. 
 
3.3.3 Stimulation length  
As previously stated in the Introduction, the duration of the stimulation with ATP is an 
important factor that determines which ATP receptors are preferentially activated, P2YR 
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or P2XR. As I was particularly interested in studying the effect of adenosine modulation 
upon the initial transient peak, mediated mostly by P2YR, the stimulation length should 
be as small as possible. 100 ms is the minimum technically possible due to limitations of 
the injector, nevertheless, the response elicited using 10 μM ATP (100 ms) is mostly 
inexistent or undetectable. For this reason, 200 ms of stimulation were used for all 
experiments. This stimulus (10μM ATP for 200 ms) triggers a small but visible Ca2+ peak, in 
which drug effects could be discerned.   
Experimental conditions determined, so far, are close to the physiological situation 
because stimulation was achieved with a low ATP (10 μM) concentration for a brief (200 
ms) period of time, when compared to previous works. Alloisio et al. (2004) used a 
stimulus of 0.3 μM or 10 μM of ATP with a duration up to hundreds of seconds (50 – 400 
seconds). In this case stimulus length is too long and cell response might reach saturation, 
which would not allow evaluation of signal modulation. 
The optimized conditions (10 μM ATP for 200 ms) allowed to perform repeated 
stimulations for a considerable period of time (≈ 60 minutes) so that different 
pharmacological situations could be tested. This is advantageous because it allowed direct 
comparison of amplitudes of peaks obtained in the presence and absence of test drugs for 
the same cell and also direct comparison of results from different pharmacological 
approaches.  
 
3.3.4 Rate of the perfusion medium 
Throughout experiments, cells were continuously perfused with HEPES buffer or the test 
drug at a rate of approximately 1.5mL/minute. This rate is similar to what was used by 
other authors, 1-1.5 mL/minute (Jiménez et al., 1999) and 2.5 mL/minute (Alloisio et al., 
2004).  
In initial experiments, the medium flow was stopped before stimulation, and different 
intervals of time were tested. By stopping the flow, the medium stabilized before the 
stimulus was applied and therefore did not influence cell response. Nonetheless, using 
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this approach, cell response was extended because ATP and consequently adenosine were 
not instantly washed out. This was a disadvantage because it easily saturates cell 
response, masking drug effect. For this reason, it was decided to keep the perfusion 
medium always on, so that the rapid flow prevents ATP accumulation. Furthermore, 
constant buffer flow did not appreciable affect the stability of cell response.  
 
3.3.5 Incubation and perfusion temperatures  
Temperature is an important factor in any cellular experiment because it directly 
influences cell activity and consequently cell response. In this particular case, both 
incubation and perfusion temperatures are important. Cells were incubated at 37oC in an 
incubator, with controlled conditions, in order to maintain cell viability for a longer period 
of time. Initially, cells were incubated at RT (22oC) and no appreciable differences in their 
responses seem to occur, when compared to cells incubated at 37oC. However, by direct 
cell observation, it appeared that cells were not so intensively fluorescent. This is 
probably due to less uptake of fluorochrome at lower temperatures, although to confirm 
this idea the actual emitted fluorescence had to be quantified. For these reasons, cells 
were incubated at 37oC as previously described by several authors (Jiménez et al., 1999; 
Alloisio et al., 2004; Fischer et al., 2009).  
The incubation period should not be too long to avoid compartmentalization of the 
indicator dye in intracellular compartments, therefore cells were incubated for 45 
minutes as described by Alloisio et al. (2004) rather than for 60 minutes (Jiménez et al., 
1999). Incubating cells for less than 45 minutes is not a good option because internalized 
dye might not underwent complete removal of AM ester groups and therefore the 
fluorochrome might leak from the cell.  
Concerning the temperature of the perfusion medium, experiments were performed both 
at RT (22oC) and at 30oC. The major difference was that, at 30oC, the basal [Ca2+]i and 
transient amplitude to ATP stimulation were augmented. This increase is probably due to 
higher cellular activity and is not favorable because it approximates cell response to its 
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maximum. Furthermore, technically, to ensure that this high temperature (30oC) was 
maintained when changing the medium, through a semi-automatic tap system, was 
difficult. As slight changes in temperature are a source of destabilization it was decided to 
perform all experiments at RT (22oC). 
It is likely that temperature also affects the characteristics of the Ca2+ probe employed, 
such as, the fluorescence and the Kd. Nonetheless, in the particular case of Fura-2 it was 
reported that the florescence does not vary significantly over a broad range of 
temperatures (0oC-40oC) in the hour following solution preparation (Oliver et al., 2000). 
Furthermore, since Fura-2 is a ratiometric dye, both bound and unbound forms of the dye 
are affected equally, concealing the destabilization in the final ratio value.     
 
3.4 Culture characterization 
3.4.1 Immunocytochemistry   
Cell population was characterized by immunocytochemistry using specific antibodies for 
GFAP (Glial Fibrillary acidic protein), an astrocytic masker, MAP2, a neuronal marker, and 
CD11b, a microglial cell marker. DIC 14 cortical astrocytes in 24-well plates were washed 
with PBS (2x5minutes), to remove DMEM medium, and then fixed with 4% 
paraformaldehyde (PFA) in PBS for 20 minutes. Cells were washed again with PBS 
(2x5minutes) and then kept with this medium in the fridge (4oC). These cells could be used 
up to one month after the fixation process. DIC 14 was chosen for fixation because it 
corresponds approximately to the time period of Ca2+ experiments (DIC 9 – DIC 14). The 
PFA reagent used here establishes cross-link bridges between cytoskeleton proteins, 
preserving almost intact the cellular architecture.  
At the day of the experiment, cells were firstly permeabilized with 0.05%Triton, a nonionic 
detergent, for 10-15 minutes followed by a washing step with PBS (2x5minutes). Blockade 
was successfully achieved by 30 minute incubation with 0.25% gelatin in PBS, for MAP-
2/GFAP staining, or 10% goat serum/0.03% triton in PBS, for CD11b/GFAP staining. Gelatin 
and goat serum interact with possible epitopes increasing binding competition and 
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consequently decreasing nonspecific binding. Primary antibodies were incubated 
overnight at 4oC, with agitation. Secondary antibodies were incubated for 1 hour at RT, 
also with agitation. Both primary and secondary antibodies were diluted in 0.1% gelatin or 
10% goat serum/0.03% triton in PBS for MAP-2/GFAP and CD11b/GFAP staining, 
respectively. Nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole, 1:15000), 
which binds strongly to DNA, for 5 minutes. After antibody incubation, cells were washed 
with 0.05% PBS-Tween-20 (PBS-T) (3x5minutes). Tween-20 is a detergent used to wash 
unbounded or nonspecific bounded antibodies, decreasing nonspecific binding. After 1 
last wash with Mili-Q water, coverslips were mounted in Mowiol anti-fade mounting 
medium (Sigma®) and were let to dry for one day at RT. Afterwards the slides were kept in 
the fridge (4oC) for subsequent microscopic analysis.  
Results were analyzed through an epifluorescence microscope (Axiovert 200, Zeiss®) 
equipped with 10x and 40x amplification objectives. To detect fluorescence at different 
wavelengths specific filters were used: DAPI (blue), YFP (green) and Rhodamine (red). For 
cell count, the ImageJ® 1.44p software was used.  
 
Table 3.2 - Primary and secondary antibodies used in immunocytochemistry experiments to target 
different cell populations: astrocytes, microglial cells and neurons.  
Cell type 
Target 
protein  
Primary 
antibody 
Animal Dilution Secondary antibody Dilution 
Astrocytes GFAP 
SIGMA® Rabbit 1:100 
goat anti-rabbit  
Alexa 568, Invitrogen® 
1:500 
Chemicon® Mouse 1.100 
goat anti-mouse Alexa 
488, Invitrogen® 
Microglial 
cells 
CD11b Serotec® Mouse 1:500 
Neurons  MAP-2 Chemicon® Mouse 1:200 
Goat anti-mouse Alexa 
568, Invitrogen® 
 
3.4.2 Western blot and protein quantification  
The expression of purinergic ATP (P2Y1) and adenosine (A1 and A2A) receptors in primary 
astrocytic cultures was detected by western blot technique using specific antibodies for 
each receptor. Firstly, I applied the lysis buffer method to detect these proteins in DIC 14 
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cultures and later the sucrose buffer method was applied to detect A2AR in DIC14 and 
DIC21 cultures.  
 
Lysis buffer method – P2Y1R, A1R and A2AR 
DIC 14 cortical astrocytes plated in 100-mm-diameter glass bottom microwell dishes were 
washed twice with cold PBS (in mM: 137 NaCl; 2.1 KCl, 1.8 KH2PO4; 10 NaH2PO4) and then 
lysed by adding 2.5 mL of lysis buffer (in mM: 25 Tris base at pH 7.5, 150 NaCl, 1 EDTA, 1% 
Triton X-100 plus EDTA-free protease inhibitors cocktail (Roche®) and also 5 mM N-
Ethylmaleimide (NEM) (Sigma®) and 0.2 mM Phenylmethylsulfonyl fluoride (PMSF) 
(Sigma®)). After 30 minute incubation in ice, cellular membranes were mechanically 
dissociated by pipetting through a P1000 tip, followed by 10-15 minutes incubation in the 
fridge with agitation. After 15 minute centrifugation (25,000g) at 4oC, the supernatant was 
transferred to an eppendorf and frost (-20oC) for later protein quantification and western 
blot.  
Prior to western blot, protein denaturation was achieved using sample buffer (70 mM 
Tris-HCl, 6% glycerol, 2% SDS, 120 mM dithiothreitol, 0.0024% Bromophenol Blue, pH 6.8) 
for 10 minute, at 70oC. Tris-glycine SDS-polyacrylamide gel for electrophoresis was 
prepared using 10% resolving gel and 5% stacking gel. The apparatus was mounted with 
running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) and equal volumes of all the 
samples were loaded into the gel (20 μg of protein) (see  
Table 3.3). Samples were stacked by running at 80 V and resolved at 140 V.  
Proteins were transferred from the gel into the polyvinylidene difluoride (PVDF) 
membrane at maximum current for about 1h30min. Membranes were previously 
activated with methanol for about 15 seconds. For the transference, transfer buffer was 
used (24 mM Tris, 182 mM glycine, 15% methanol). Afterwards, membranes were washed 
in 0.05% PBS-T, followed by blockage with 5% non-fat powered milk (w/v) in 0.05% PBS-T 
for 1 hour at RT. During blockage and until the end of the experiment membranes were 
constantly shaken. Then again membranes were washed with 0.05% PBS-T (3x5minutes).  
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Membranes were incubated overnight at 4oC with primary antibodies, diluted in 0.02% 
NaN3/3% BSA solution in 0.05% PBS-T ( 
Table 3.3). Then membranes were washed with 0.05% PBS-T (3x5minutes). Followed 
secondary antibody incubation for 1 hour at RT. The secondary antibodies were diluted in 
5% non-fat powered milk (w/v) in 0.05% PBS-T. Again membranes were washed with 
0.05% PBS-T (4x10minutes) and one last time with PBS. For protein detection the ECL plus 
WB detection reagent (GE Health Care®) was used. This reagent will luminesce when 
exposed to the reporter on the secondary antibodies and the chemiluminescence emitted 
is detected by the X-Ray film (Fugifilm®).  
  
Sucrose buffer method - A1R, A2AR 
DIC 14 and DIC 21 cortical astrocytes plated in 100-mm-diameter glass bottom microwell 
dishes were washed twice with cold PBS and then lysed by adding 800 μL of 0.32M 
sucrose buffer with 50 mM Tris plus protease inhibitors cocktail (ROCHE®), pH 7.6. Then 
cells were mechanically dissociated by rapidly scraping the plate with a cell scraper and 
pipeting with a syringe. After 10 minute centrifugation (1000g) at 4oC, the supernatant 
was transferred to an eppendorf and frost (-20oC) for later protein quantification and 
western blot. Protein concentration was achieved at 70oC in a water bath. Once again, DIC 
14 was chosen and also DIC 21 because at 3 weeks, cells are more confluent and the total 
amount of A2AR is higher, which supposedly makes it easier for detection. 
Prior to the western blot, protein denaturation was achieved using sample buffer for 30 
minute, at 37oC. Sample loading (125 μg of protein) and running were performed as 
previously described. Protein transference into the PVDF membrane and blockade in 5% 
non-fat powdered milk (w/v) in Tris Buffered Saline (TBS) (in mM: 0.2 Tris, 137 NaCl) with 
0.1% Tween-20 (TBS-T), were performed as described for the lysis buffer method. In the 
presence of constant shake, membranes were washed with 0.1% TBS-T (3x5minutes).   
Membranes were incubated overnight at 4oC with primary antibodies, diluted in 0.02% 
NaN3/3% BSA solution in 0.1% TBS-T ( 
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Table 3.3). Membranes were washed with 0.1% TBS-T (4x10minutes). Followed secondary 
antibody incubation for 1 hour at RT. The secondary antibodies were diluted in 5% non-fat 
powdered milk (w/v) in 0.1% TBS-T. Again membranes were washed with 0.1% TBS-T 
(4x10minutes) to remove nonspecific bonded antibodies and one final time with TBS. 
Proteins were detected as described previously.  
 
Table 3.3 - Protein loading, primary and secondary antibodies used in western blot to detect P2 
(P2Y1) and P1 (A1 and A2A) receptors and α-tubulin, an internal control.  
Protein DIC 
Lysis 
method 
Protein 
Loading 
(μg) 
Primary 
Antibody 
Animal Dilution 
Secondary 
Antibody 
Dilution 
P2Y1R 14 
Lysis 
Buffer 
20 
Alamone 
labs® 
(APR-009) 
Rabbit 1:200 
goat anti-rabbit 
(sc-2004) 
 
goat anti-
mouse 
(sc-2005) 
 
Santa Cruz 
Biotechnology® 
1:10000 
A1R 
14 
Lysis 
Buffer 
20 
Affinity 
BioReagents® 
(PA1-041A) 
Rabbit 1:1000 1:15000 14 
Sucrose 
Buffer 
125 
21 
Sucrose 
Buffer 
125 
A2AR 
14 
Lysis 
Buffer 
20 
Upstate® 
(05-717) 
Mouse 1:2000 1:5000 14 
Sucrose 
Buffer 
125 
21 
Sucrose 
Buffer 
125 
α-
Tubulin 
- - - 
Abcam® 
(ab4074) 
Rabbit 1:5000 1:10000 
 
Protein Quantification 
Total protein quantification was performed according to the Bradford method assay 
(Bradford, 1976) using the Bio-Rad® Protein assay kit. Different BSA concentrations (in 
mg/mL: 0, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1) were used as standard. Results 
of absorbance at 750 nm (Abs 750 nm) vs. [BSA] are plotted in Figure 3.11. The equation 
from the linear regression was used to calculate the concentration of each sample from 
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their Abs 750 nm and therefore determine the volume that corresponds to either 20 or 
125 μg of protein. 
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Figure 3.11 - Graphic representation of the variation of absorbance at 750 nm for various BSA 
solutions of known concentration.    
 
3.5 Statistical Analysis  
Bar plots represent mean ± standard error mean (s.e.m.). Statistical significance of 
differences between mean values was evaluated using a parametric test, one-way ANOVA 
for repeated measures, with a post-Bonferroni test to compare all pairs of columns (95% 
confidence interval). Differences were regarded as statistically significant for p < 0.05. For 
fold increase values, statistical analysis was performed using a one-way analysis of 
variance with a post-Dunnett test to compare all columns vs. a control column (fold 
increase = 1, which represents no variation of cell response upon drug perfusion). When 
comparing statistical significance, the following code was used: ns – non significant; * p < 
0.05; ** p < 0.01; ***p < 0.0001. 
   
 
51 
 
4 Results 
4.1 ATP induces Ca2+  signalling 
A brief stimulation of P2R with 10 μM ATP (0.2 seconds) induced a sharp and fast Ca2+ 
peak (Figure 4.1; Figure 4.2). The [Ca2+]i returned to the basal levels approximately 20 
seconds after the stimulus. Signal transients induced by a prolonged 10 μM ATP stimulus 
(≥ 20 seconds) presented a biphasic behavior constituted by an initial large transient peak 
followed by a smaller sustained phase (Figure 4.1). As the aim of this project was to study 
the modulation of the initial Ca2+ peak, mediated mostly by P2YR (Alloisio et al., 2004), it 
was decided to use a brief stimulus (0.2 seconds) in all experiments. 
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Figure 4.1 – Representative Ca
2+
-mediated responses elicited by 10 μM ATP for different stimulus 
length (0.2, 20 and 50 seconds). Cells were perfused only with HEPES buffer, no pharmacological 
treatment was applied.  
 
When perfusing cells with a low-Ca2+ HEPES buffer, the amplitude of the transients 
decreased throughout the time, nevertheless, cells continued to respond. Adding Ca2+ to 
the perfusion medium was enough to completely reverse the effect observed (Figure 4.3). 
These observations indicate that both metabotropic P2YR and ionotropic P2XR contribute 
to the cytoplasmic Ca2+ rise induced by ATP.  
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A decrease in the baseline [Ca2+]i was observed in the presence of low-Ca
2+ medium, 
which is promptly reverted when Ca2+ is added to the medium, reinforcing the idea that 
external Ca2+ entry is important to maintain [Ca2+]i stable.  
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Figure 4.2 – Representative sequence of images of a Ca
2+
 transient. The color scale corresponds to 
fluorescence ratio (F340/F380), which allows to evaluate variations in [Ca
2+
]i.  
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Figure 4.3 – Representative Ca
2+
-mediated responses to 10 μM ATP (0.2 seconds) for a low-Ca2+ 
medium experiment. The perfusion medium was changed from the initial HEPES buffer with Ca
2+
 
([Ca
2+
]free = 2  x 10
-3
 M) to low-Ca
2+
 HEPES buffer ([Ca
2+
]free = 1.6  x 10
-7
 M) and back again to regular 
buffer for the washout. Cells were continuously stimulated with ATP every 5 minutes. 
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4.2 Ca2+  signalling modulation by adenosine  
4.2.1 Modulation by ADOR activation 
To evaluate the role of adenosine receptors, particularly A2AR, in Ca
2+ signalling 
modulation, an adenosine analogue - 2-chloro-adenosine (1μM CADO), which binds 
unselectively to adenosine receptors, was used. CADO presents a high structural similarity 
to adenosine but is resistant to metabolization by ectoenzymes or uptake by cells. An A2AR 
selective agonist, CGS 21680 (30 nM), was also used.  
The adenosine analogue, 1 μM CADO, markedly enhanced the signal response induced by 
10 μM ATP (fold increase: 3.19 ± 0.30, n = 73 cells, p < 0.0001) (Figure 4.4 (a); Figure 4.5 
(a)). The magnitude of the effect corresponds to the ratio between the amplitude of the 
transient obtained in the presence of the agonist and the amplitude of the transient 
obtained in the absence of the agonist, for each cell. The A2AR selective agonist, 30 nM 
CGS 21680, mimicked the facilitatory effect (fold increase: 2.92 ± 0.32, n = 80 cells, p < 
0.0001) (Figure 4.4 (a); Figure 4.5 (a)). This result indicates the involvement of A2AR in the 
modulatory effect.  
In the presence of higher stimuli (50 μM and 100 μM of ATP) there was no significant 
potentiation of Ca2+ responses to the agonists, 1 μM CADO and 30 nM CGS 21680 (data 
not shown).  
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Figure 4.4 - Representative Ca
2+
 mediated responses to 10 μM ATP (200 ms) for experiments with 
(a) 1 μM CADO and (b) 30 nM CGS 21680. For each experiment is presented a response in the 
presence of HEPES buffer, test drug, after the washout with HEPES buffer and triggered by 100 μM 
ATP.  
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Figure 4.5 – Fold increase of 10 μM ATP-induced responses, observed in the presence of 1 μM 
CADO and 30 nM CGS 21680. (a) Mean values from the entire pool of cells studied (CADO, n = 73 
cells, 19 experiments; CGS 21680, n = 80 cells, 24 experiments). (b1) Mean values considering only 
those cells that presented a control/maximal response < 20% (CADO, n = 31 cells, 12 experiments; 
CGS 21680, n = 34 cells, 16 experiments). (b2) Mean values considering only those cells that 
presented a control/maximal response > 20% (CADO, n = 42 cells, 17 experiments; CGS 21680, n = 
46 cells, 24 experiments). Statistical significance: ns – non significant, ** p < 0.01, *** p < 0.0001.  
 
Another parameter calculated was the percentage of control/maximal response. This 
parameter is the ratio between the amplitude of the transient triggered by 10 μM ATP 
stimulation and the amplitude of the transient triggered by 100 μM ATP, in the absence of 
test drugs. When plotting the fold increase vs. control/maximal response to all the cells 
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studied for CADO and CGS 21680, separately, an interesting correlation between this 
parameter and the effect of CADO and CGS 21680 was evident (Figure 4.6 (a) and (b)).  
Cells that presented a smaller control/maximal response, in particular those under 20%, 
underwent a higher increase in response in the presence of the agonists, and therefore 
presented a higher fold increase (CADO 4.77 ± 0.56, n = 31 cells, p < 0.0001; CGS 21680 
5.03 ± 0.59, n = 34 cells, p < 0.0001) (Figure 4.5 (b1); Figure 4.6 (a) and (b)). That is to say 
that, cells presenting a small control response to 10 μM ATP underwent a markedly 
potentiation in Ca2+ response in the presence of the adenosine receptors agonist (Figure 
4.6 (a1) and (b1)). The potentiation induced by the adenosine receptor agonist decreased 
as control/maximal response increased, meaning that cells presenting a higher control 
response to 10 μM ATP are characterized by a smaller fold increase value caused by 
adenosine receptor stimulation (CADO 2.39 ± 0.42, n = 42 cells, p < 0.01; CGS 21680 1.37 ± 
0.08, n = 46 cells, non significant)) (Figure 4.5 (b2); Figure 4.6 (a2) and (b2)). These 
observations clearly show the heterogeneity in cell response within the cell population. 
To analyse cell response to drugs throughout experiments, bar plots were made to 
represent the mean of Ca2+ transient amplitude in the absence and in the presence of the 
agonist, after the washout with HEPES buffer and also the maximal response triggered by 
100 μM ATP (Figure 4.7). The mean amplitude of Ca2+ transients was presented  for the 
entire pool of cells (Figure 4.7 (a) and (b)) and separately  for cells that had 
control/maximal response under 20% (Figure 4.7 (a1) and (b1)) and above 20% (Figure 4.7 
(a2) and (b2)). As shown, the facilitatory effect upon ATP-induced Ca2+ signals mediated 
by both agonists (1 μM CADO and 30 nM CGS 21680) was reverted by washout with 
HEPES buffer (Figure 4.7 (a) and (b)). This indicates that the effect was due to the agonist 
perfusion and not caused by any other interference. For CADO, the unselective agonist, 
the potentiation was completely reverted during washout while for CGS 21680, the A2AR 
selective agonist, the reversion was not so effective. 
The amplitude of Ca2+ responses in the presence of CGS 21680 (30 nM) represented 66% 
of the maximal response amplitude (100 μM ATP), which indicates that the saturation 
plateau was not reached with CGS 21680 perfusion (Figure 4.7 (b)). On the contrary, the 
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amplitude of Ca2+ responses in the presence of CADO (1 μM) represented 94% of the 
maximal response amplitude (100 μM ATP), which means that the saturation plateau was 
reached with the perfusion of CADO (Figure 4.7 (a)). Therefore in the case of CADO, the 
ceiling effect may camouflage the magnitude of the effect. For this reason, lower 
concentrations of CADO need to be tested in the future to compare the efficacy of both 
CADO and CGS 21680 to enhance ATP-induced Ca2+ signals in astrocytes.  
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Figure 4.6 – Cell distribution for values of fold increase vs. control/maximal values for (a) 1 μM 
CADO and (b) 30 nM CGS 21680. Representative Ca
2+
 mediated responses to 10 μM ATP (200 ms) 
for experiments with 1μM CADO or 30nM CGS 21680, which presented control/maximal response 
< 20% ((a1) and (b1)) or > 20% ((a2) and (b2)). For each experiment is presented a response in the 
presence of HEPES buffer, test drug (CADO or CGS 21680) and after the washout with HEPES 
buffer. 
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When comparing  the Ca2+ response obtained for the entire pool of cells (Figure 4.7 (a) 
and (b)) with Ca2+ response obtained for those cells that presented control/maximal 
response under 20%  (Figure 4.7 (a1) and (b1)), it can be seen that the amplitude of ATP-
induced  Ca2+ transients (as Δ[Ca2+]i) in the presence of the agonist is similar (CADO – (a) 
342.80 ± 50.05, n = 11 cells vs. (a1) 272.80 ± 99.39, n = 5 cells); CGS 21680 – (b) 229.30 ± 
33.12, n = 13 cells vs. (b1) 219.70 ± 57.15, n = 7 cells). Therefore, the higher values of fold 
increase observed previously for cells with control/maximal response under 20% (Figure 
4.5 (b1)) are probably not due to a higher amplitude of drug response but can be 
explained by a smaller  amplitude of the control response in the absence of the test drug 
(Figure 4.7 (a1) and (b1)).  
By analysing the results obtained for cells that presented control/maximal response above 
20% (Figure 4.7 (a2) and (b2)), one can observe that CGS 21680 did not induced a 
significant increase in cell response. CADO potentiated Ca2+ response but the fold increase 
was small when compared to the other groups of cells (Figure 4.5).  
Prior to 10 μM ATP stimulation, the basal [Ca2+]i of cells for these two groups 
(control/maximal response < 20% vs. control/maximal response > 20%) were not 
significantly different (p < 0.05) (data not shown).   
In spite of all the clear differences between the two populations of cells, when pooling all 
data together (Figure 4.7 (a) e (b)) the effect of CADO and CGS 21680 remained clear. 
Therefore, from now on, data will be presented as amplitude of Ca2+ responses for the 
entire pool of cells studied.         
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Figure 4.7 – Amplitude of Ca
2+
 transients elicited by 10 μM ATP for control, drug, washout and 
maximal responses (100 μM ATP) for 1 μM CADO and 30 nM CGS 21680. Plots (a) and (b) present 
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mean values for the entire pool of cells. Plots (a1), (b1) and (a2), (b2) present mean values for cells 
that presented control/maximal response < 20% and > 20%, respectively. In each plot is 
discriminated the drug applied through the perfusion medium, 1 μM CADO or 30 nM CGS 21680, 
and the stimulus applied, 10 μM or 100 μM of ATP. (a) n = 11 cells, 4 experiments; (b) n = 13 cells, 6 
experiments; (a1) n = 5 cells, 2 experiments; (b1) n = 7 cells, 4 experiments; (a2) n = 6 cells, 2 
experiments; (b2) n = 6 cells, 4 experiments. Statistical significance: ns – non significant, * p < 0.05, 
** p < 0.01.  
 
4.2.2  Modulation by ADOR blockade 
The effect of an A2AR selective antagonist (SCH 58216) and an A1R selective antagonist 
(DPCPX) in Ca2+ signalling modulation were also studied. Data analysis similar to the one 
presented previously for the effect of agonists was performed. Neither the A2AR 
antagonist (50 nM SCH 58261), nor the A1R antagonist (50 nM DPCPX) influenced ATP-
induced Ca2+ responses, and therefore no significant variations on fold increase were 
obtained (Figure 4.8; Figure 4.9).  
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Figure 4.8 - Representative Ca
2+
 mediated responses to 10 μM ATP (200 ms) for experiments with 
(a) 50 nM SCH 58261 and (b) 50 nM DPCPX. For each experiment is presented a control response in 
the presence of HEPES buffer, test drug, after the washout with HEPES buffer and triggered by 
100 μM ATP.  
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Figure 4.9 - Fold increase of 10 μM ATP-induced responses, observed in the presence of 50 nM SCH 
58261 and 50 nM DPCPX. Mean values are presented for the entire pool of cells studied (SCH 
58261, n = 26 cells, 7 experiments; DPCPX, n = 39 cells, 7 experiments). Statistical significance: ns – 
non significant.  
 
Also, the plot of fold increase vs. control/maximal response did not present the 
correlation observed earlier for the two agonists, which was expected since the 
antagonists induced no variations in Ca2+ response (Figure 4.10).  
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Figure 4.10 – Cell distribution for values of fold increase vs. control/maximal values for (a) 50 nM 
SCH 58261 and (b) 50 nM DPCPX. Percentage values of control/maximal response above 100% 
correspond to those cells that had a maximal response (100 μM ATP) smaller than the control 
response (10 μM ATP).  
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Comprehensive analysis of cell response to adenosine receptors antagonists throughout 
experiments confirmed that both A2AR and A1R antagonists did not affect Ca
2+ transient 
amplitude in a statistical significant way (Figure 4.11). Surprisingly, for DPCPX there was a 
significant decrease in the amplitude of ATP-induced Ca2+ transients after the washout, for 
which I have no possible explanation yet (Figure 4.11 (b)).   
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Figure 4.11 – Amplitude of Ca
2+
 transients elicited by 10 μM ATP for control, drug, washout and 
maximal responses (100 μM ATP) for 50 nM SCH 58261 and 50 nM DPCPX. Both plots present 
mean results from the entire pool of cells studied. In each plot is discriminated the drug applied 
through the perfusion medium, 50 nM SCH 58261 or 50 nM DPCPX, and the stimulus applied, 10 
μM or 100 μM of ATP. (a) n = 26 cells, 7 experiments; (b) n = 39 cells, 7 experiments. Statistical 
significance: ns – non significant, ** p < 0.01.  
 
4.2.3  Ca2+  signalling modulation via A2AR 
Results reported above for the effect of CGS 21680 indicate the contribution of A2AR in 
Ca2+ signalling potentiation. To confirm A2AR involvement, experiments were performed 
where the potentiation of Ca2+ response was first induced, applying either CADO or CGS 
21680, and then the perfusion medium was changed to a mixture of the agonist and the 
A2AR selective antagonist (SCH 58261). 
The facilitatory effect mediated by the unselective (1 μM CADO) and A2AR selective (30 
nM CGS 21680) agonists was completely reverted by blockade of A2AR, using a selective 
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antagonist (50 nM SCH 58261) (Figure 4.12; Figure 4.13). These results clearly show that 
the potentiation mechanism is mediated by A2AR. 
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Figure 4.12 - Representative Ca
2+
 mediated responses to 10 μM ATP (200 ms) for experiments with 
(a) 1μM CADO / 50nM SCH 58261 and (b) 30nM CGS 21680 / 50nM SCH 58261. For each 
experiment is presented a response in the presence of HEPES buffer, test drug (CADO or CGS 
21680), agonist/antagonist mixture and triggered by 100 μM ATP.  
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Figure 4.13 – Amplitude of Ca
2+
 transients elicited by ATP for control, drug, washout and maximal 
responses using agonists (1μM CADO or 30nM CGS 21680) and antagonist (50 nM SCH 58261). 
Plots present mean results from the entire pool of cells studied. In each plot is discriminated the 
drug mixture applied through the perfusion medium and the stimulus applied, 10 μM or 100 μM of 
ATP. (a) n = 16 cells, 5 experiments; (b) n = 25 cells, 7 experiments. Statistical significance: ns – non 
significant, *** p < 0.0001.  
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4.3 A1R-A2 AR cooperation in Ca2+  signalling modulation 
In order to test if the adenosine modulation over ATP-induced Ca2+ signalling was 
dependent on A1R-A2AR cooperation, an A1R selective antagonist, DPCPX, was used.  
Unexpectedly, the potentiation mediated by the unselective (1 μM CADO) and A2AR 
selective (30 nM CGS 21680) agonists was completely reverted by blockade of A1R, using a 
selective concentration (50 nM) of DPCPX) (Figure 4.14; Figure 4.15). Overall, results 
reported in the prior section (4.2.3) and here indicate that the activation of both A1R and 
A2AR is required for adenosine to mediate the facilitation of ATP-induced Ca
2+ responses, a 
mechanism that denotes A1R-A2AR cooperation.  
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Figure 4.14 - Representative Ca
2+
 mediated responses to 10 μM ATP (200 ms) for experiments with 
(a) 1μM CADO/ 50nM DPCPX and (b) 30nM CGS 21680 / 50nM DPCPX. For each experiment is 
presented a response in the presence of HEPES buffer, test drug (CADO or CGS 21680), 
agonist/antagonist mixture and triggered by 100 μM ATP.  
 
Averaged analysis showed that DPCPX, the A1R selective antagonist, reverted the 
facilitatory effect towards and even below the control levels, obtained prior to CADO or 
CGS 21680 perfusion (Figure 4.15 (a) and (b)).  
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Figure 4.15 – Amplitude of Ca
2+
 transients elicited by ATP for control, drug, washout and maximal 
responses using agonists (1μM CADO or 30nM CGS 21680) and antagonist (50 nM DPCPX). Plots 
present mean results from the entire pool of cells studied. In each plot is discriminated the drug 
mixture applied through the perfusion medium and the stimulus applied, 10 μM or 100 μM of ATP. 
(a) n = 48 cells, 10 experiments; (b) n = 43 cells, 11 experiments. Statistical significance: ns – non 
significant, * p < 0.05, *** p < 0.0001.  
 
4.4 Culture Characterization 
Relevant for this project was the characterization of the astrocytic primary cultures used 
in Ca2+ imaging experiments. Firstly, the percentages of different cell populations present 
in culture were determined by immunocytochemistry. Then the presence of A1R, A2AR and 
P2Y1R was confirmed by western blot.  
 
4.4.1 Cell counting by Immunocytochemistry  
Astrocytic primary cultures, at 14 days in culture (DIC14), are mainly constituted by 
astrocytes (> 90%) and few microglial cells (Figure 4.16) and therefore, according to Saura 
(2007), are designated enriched primary astrocytic cultures. Neurons are very rare, two or 
three per vision field (mean total of 600 cells per vision field) (Figure 4.17) due to the 
protocol applied, namely culture medium composition, and because after birth (P0-P2) 
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neuronal precursor cells have already differentiated into neurons, in contrast, astrocyte 
precursor cells are still present at P0-P2, giving rise to the astrocytic population. For this 
reason, it was assumed that to calculate the percentage of astrocytes and microglial cells, 
neurons could be disregarded. Therefore the number of astrocytes was considered as the 
difference between the total number of cells, given by nuclei count, and the number of 
microglial cells. 
 
GFAP
CD11b
DAPI 10 μm
10 μm
 
Figure 4.16 - Immunofluorescence images, obtained with a epifluorescence microscope, 
representing astrocytes (red), microglial cells (green) and nuclei (blue), from a culture at DIC 14 
(40x amplification lens). 
 
Microglial cells are known to express a plethora of P2 and P1 receptors and have a Ca2+ 
excitable mechanism similar to astrocytes (Verkhratsky et al., 1998; Abbracchio & Ceruti, 
2006; Butt, 2011). For these reasons, it was considered relevant to evaluate the degree of 
microglia contamination. 
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Figure 4.17 - (a) Immunofluorescence image, obtained with a epifluorescence microscope, 
representative of a primary culture (10X amplification lens). (a1) Enlarged image representing 
astrocytes (green), neurons (red) and nuclei (blue) (40x amplification lens). (b) 
Immunofluorescence images representing culture amplification (40x) for each fluorescence filter.  
 
To minimize microglia contamination, an extra 5h cellular shake at DIC6, the day before 
cell replating, was added to the primary culture protocol that was previously applied in 
the host laboratory (previously described by Biber et al. (1997)). According to several 
authors (Jiménez et al., 1999; Du et al., 2010), culture shaking followed by supernatant 
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removal is a good method to remove microglia and to obtain enriched astrocytic cultures. 
As microglial cells grow mostly on top of astrocytes, they are not attached to the bottom 
of the flask and therefore are easier to detach by shaking. To test if this also applied to 
our culture conditions, two different cell batches were prepared from the same culture. 
One of them underwent this extra shake (4-5 hours at DIC 6) and the other did not. The 
purpose was to calculate the percentage of microglial cells for both cell batches in order 
to understand if there was less microglia in cultures that underwent the extra shaking 
period.  
Primary cultures that were not submitted to the extra 5h shake are mainly constituted by 
astrocytes (≈ 95%) and microglial cells (Table 4.1). The percentage of astrocytes after the 
extra 5h shake was higher (≈ 98%), which indicates that more microglial cells were 
discarded during the extra shaking step. The increase in astrocyte percentage observed 
here is similar to the one observed by Du et al. (2010) between shaken once 
(94.8±1.325%) and shaken twice (96.5±1.080%) cultures.  
 
Table 4.1 - Results from cell counting. Mean total number of cells, percentage of astrocytes and of 
microglial cells for two independent cultures, applying the two different protocols. 
Treatment Culture 
Mean total number of cells  
per vision field 
Astrocytes (%) Microglial cells (%) 
No shake 
1 688 97.33 2.67 
2 209 92.06 7.94 
Mean - 94.7 5.3 
5h shake 
1 875 99.31 0.69 
2 619 95.59 4.41 
Mean - 97.5 2.5 
    
Overall, results indicate that adding a 5h shaking step to the protocol produces cultures 
with higher percentage of astrocytes and therefore this new step was added to the 
protocol. Besides, Ca2+ imaging experiments performed with cultures that underwent 
these two different treatments did not presented significant changes in Ca2+ signalling 
(data not shown). 
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Other alternatives that could also be used are laminin that inhibits microglial growth and 
promotes astroglial growth or ARA-C, a mitotic inhibitor, that is added to stop mitosis 
after astrocytes have reached confluence (Saura, 2007). Given the high enrichment of the 
cultures in astrocytes, I decided not to use growth inhibitors.   
 
Astrocytes are a very heterogeneous cell population and it is possible to visually 
distinguish different types of astrocytes. Although, it was not performed any 
immunocytochemistry for specific astrocytic markers, because it was beyond the scope of 
this project, it appeared that Type-I and Type-II astrocytes were present in cultures 
(Figure 4.18). These two types of cells can be easily differentiated by their shape as 
explained earlier (see section 1.1.1, in Introduction). Nevertheless, differences between 
this two types of astrocytes, at the molecular level, are not well characterized and most of 
the work published was performed on Type-I astrocytes. For these reasons, Ca2+ imaging 
experiments presented here were performed using, presumably, Type-I astrocytes that 
can be visually differentiated because they are bigger in size.  
 
1
2
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Figure 4.18 - Immunofluorescence image of a primary astrocytic culture. Type-I (1) and Type-II (2) 
astrocytes (red), nuclei (blue). This image is not representative of Type-I/Type-II astrocytes 
percentages in cultures. 
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4.4.2 Western blot analysis of P2Y1 ,  A1  and A2 A receptors 
Western blot analysis of primary cultures using the lysis buffer method showed the 
presence of P2Y1R (42 kDa) and A1R (37 kDa) in cultures at DIC 14 (Figure 4.19). However, 
with this method, it was not possible to detect A2AR (43 kDa). The unspecific bands 
present at higher molecular weight (≈ 50-60 kDa) do not correspond to A2AR but are 
always present when this antibody is regularly used in the laboratory. These receptors are 
difficult to detect because they are present at very low density in the cortex compared to 
other brain regions, such as, the striatum (Ribeiro et al., 2003). For this reason, in the 
following experiments, a sample of striatum was used as positive control for A2AR. 
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Figure 4.19 - Results of western blot experiments using lysis buffer method for astrocytes at DIC 14 
(Protein leading: 20 μg). (a) P2Y1R (42 kDa), (b) A1R (37 kDa) and (c) no visible band corresponding 
to A2AR (43 kDa). 
 
Western blot was repeated applying the sucrose buffer method to detect A1R and A2AR. 
Sucrose buffer allows a milder lysis compared to lysis buffer. Protein loading was 
increased for 125 μg of protein in wider lanes and samples at DIC 14 and DIC 21 were 
applied. In spite of being interested in detecting A2AR proteins at DIC 14, i.e. at the period 
when Ca2+ experiments were performed (DIC 9-14), once A2AR are difficult to detect, it 
was also used a sample of cells at DIC 21. At 3 weeks, cultures are more confluent and 
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therefore samples are expected to have a higher quantity of A2AR, which should be easier 
to detect.  
Again, A1R (37 kDa) were detected both at DIC 14 and DIC 21, as well as tubulin (50 kDa), 
used as an internal control (Figure 4.20 (a)). Still, it was not possible to detect A2AR (43 
kDa) in any of the samples, only in striatum, the positive control (Figure 4.20 (b)). This 
could be due to the very low density of A2AR, which are undetectable by western blot, or 
these proteins were degraded during the lysis process. Therefore, the protocol needs 
further optimization.   
Nevertheless, Cristovão-Ferreira et al. (2011) already observed, in cortical astrocytes, 
relatively low expression of A2AR at DIC 14, as well as, functional effects of the receptors 
on GABA transport. Furthermore, in Ca2+ imaging experiments presented here, cells 
responded to A2AR selective activation and blockade. For these reasons, it can be 
concluded that A2AR are present in these samples. In the future, RT-PCR technique can be 
used to amplify mRNA levels present in samples and quantify them. However, it should 
always be kept in mind that the presence of mRNA does not necessarily indicate the 
presence of functional proteins.  
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Figure 4.20 - Results of western blot experiments using sucrose lysis method (Protein leading: 125 
μg). (a) A1R (37 kDa) from samples at DIC 14 and DIC 21; (b) A2AR (43 kDa) from samples at DIC 14, 
DIC 21 and striatum. 
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5 Discussion 
A brief stimulation with ATP induces a sharp and fast Ca2+ transient in cortical astrocytes. 
The work now reported clearly shows that adenosine potentiates ATP-induced Ca2+ 
transients, via A2AR activation. Furthermore, it was demonstrated that the cooperation 
between A1R and A2AR is essential for Ca
2+ signalling modulation. 
 
 
5.1 ATP induces Ca2+  signalling 
Astrocytic Ca2+ responses can be seen as a measure of cellular response to an external 
stimulus and therefore it allows to evaluate cellular communication. Here, it has been 
shown that a brief stimulus (10 μM ATP for 0.2 seconds) induces a sharp and fast Ca2+ 
transient. Results presented confirm that Ca2+ responses elicited by a prolonged stimulus 
(10 μM ATP for ≥ 20 seconds) present a biphasic behavior, an initial large transient peak 
followed by a smaller sustained phase, as previously seen by other authors (Nobile et al., 
2003 ; Alloisio et al., 2004). These authors also described that the Ca2+ influx observed in 
these two phases is mediated by different P2R subtypes. The initial peak corresponds to 
the release of Ca2+ from intracellular storages, via P2YR activation, namely P2Y1R, whose 
presence was confirmed here by western blot. The plateau is maintained by Ca2+ influx 
through ionotropic P2XR, namely P2X7R. Nevertheless, results obtained here disprove 
these previous observations by showing that both metabotropic (P2Y) and ionotropic 
(P2X) ATP receptors contribute to the Ca2+ rise when cells are activated by a brief ATP 
stimulus (10 μM ATP for 0.2 seconds).  
 
 
5.2 Ca2+  signalling modulation via A2 AR  
The experimental approach developed here uses Ca2+ imaging to study which adenosine 
receptors are involved in Ca2+ signalling modulation in primary astrocytes. The use of a 
Discussion 
  
 
72 
 
smaller ATP concentration and appropriate concentrations of each test drug, as well as, 
the stimulation pattern developed, have great advantages when compared to the 
protocols developed previously (Jiménez et al., 1999; Alloisio et al., 2004).   
A stable adenosine analogue, 1 μM CADO, markedly enhanced Ca2+ transients induced by 
10 μM ATP. Potentiation observed here was completely reversed upon washout. These 
results are in agreement with previous observations from Alloisio et al. (2004), who saw 
the potentiation of Ca2+ peaks in the presence of CADO (10 μM) and NECA (10 μM), both 
unselective agonists of adenosine receptors.  
Alloisio et al. (2004) provided pharmacological evidence that adenosine can modulate 
biphasic Ca2+ responses differently due to a differential activation of adenosine receptors. 
A2BR activation potentiates the initial peak and A1R activation downregulates the 
sustained response. Therefore, the next step was to characterize the individual role of 
adenosine receptors, particularly A2AR, in Ca
2+ signaling modulation.   
In the present study, the facilitation of ATP-induced Ca2+ responses mediated by CADO 
was mimicked by an A2AR selective agonist, CGS 21680 (30 nM). It was also shown, using a 
combination of selective agonists and antagonists, that the potentiation observed for 
both agonists (CADO and CGS 21680), is completely reverted by an A2AR selective 
antagonist, SCH 58261 (50 nM). Altogether, these results clearly show that the 
potentiation mechanism is mediated by A2AR. 
Interestingly, these findings refute results obtained by Alloisio et al. (2004) and Jimenez et 
al. (1999), who saw no modulation effect on ATP-induced Ca2+ responses when an A2AR 
selective agonist (10 μM CGS 21680) was used. These authors also used primary cultures 
from cortex and cerebellum, respectively, prepared in similar conditions to the ones used 
here. Therefore this conflicting data could be due to the unselective agonist concentration 
used by these authors, 10 μM, contrasting with the 30 nM CGS 21680 solution used here. 
At micromolar concentration, GCS 21680 not only desensitize A2AR but also activates A1R, 
making these high concentration unviable for A2AR identification (Correia-de-Sá et al., 
1991).  
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The observations that in the presence of higher stimuli (50 μM and 100 μM of ATP) there 
was no significant potentiation of Ca2+ responses to the agonists, 1 μM CADO and 30 nM 
CGS 21680, can be explained due to the fact that these ATP concentrations are 
supramaximal. When maximal response is reached, a ceiling effect is expected and it 
might camouflages a drug effect, being it a potentiation or inhibition. 
The facilitatory effect mediated by CGS 21680 was not so effectively reverted by HEPES 
washout, as in the case of CADO. Due to the its liposoluble character, CGS 21680 
molecules remain bonded to the lipidic membrane for a longer period of time. Indeed, 
CADO e much more hydrosoluble than CGS 21680 and, therefore, easier to washout. 
A2AR and A1R selective antagonists, SCH 58261 (50 nM) and DPCPX (50 nM), did not affect 
Ca2+ responses, suggesting that in the culture conditions used neither A1R nor A2AR are 
activated by endogenous extracellular adenosine.  
 
In the present study, the relation observed, for CADO and CGS 21680, between fold 
increase and control/maximal response is very interesting and supports the idea that we 
are working with a heterogeneous astrocytic cell population (Matyash & Kettenmann, 
2010). Cells with high responses to ATP (10 μM) had a smaller potentiation of Ca2+ 
responses, under adenosine modulation, compared to cells with low responses to ATP. 
These cells not only behave differently when stimulated by ATP but also are modulated in 
a different way by adenosine. Peakman and Hill (1996) reported a differential segregation 
of A2R and A1R to Type-I and Type-II astrocytes, respectively. A possible differential 
distribution of adenosine receptors in astrocytic cell populations could explain the 
differential modulation observed. Altogether, it seems to be fundamental to separately 
dissect the contribution of individual adenosine receptors for Ca2+ modulation in Type-I 
and Type-II astrocytes. 
Despite the different cellular behaviors described, it is interesting that these groups of 
cells (control/maximal response < 20% vs. control/maximal response > 20%) present 
similar basal [Ca2+]i and reached similar [Ca
2+]i upon ATP stimulation, in the presence of 
the adenosine receptors agonists, CADO and CGS 21680. The great difference was the 
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[Ca2+]i reached upon ATP stimulation in the absence of the adenosine receptor agonists. 
This can be indicative of some sort of internal cell regulation process that program cells to 
synchronize their responses and reach certain Ca2+ levels upon a given external stimulus in 
the presence of an adenosine receptor agonist. It could also indicate a physiological 
limitation, meaning that cells are not capable of reaching higher Ca2+ levels. The later 
hypothesis is very unlikely, at least for cells used in experiments with CGS 21680, because 
the Ca2+ response amplitude obtained in the presence of the A2AR selective agonist is far 
below the maximal Ca2+ response to 100 μM ATP. This is not the case for CADO, since the 
Ca2+ response amplitude obtained in the presence of the unselective agonist is similar to 
the maximal Ca2+ response, which indicates that the saturation plateau was reached. In 
this situation, the cellular Ca2+ response might not be capable to undergo further 
potentiation induced by CADO, and for this reason the facilitatory effect might be 
underestimated.  
Interestingly, the presence of internal cell regulation that programs cells for a certain 
response to a determined stimulus is a plausible idea. It is known that astrocytes are 
capable to integrate and process external inputs (Perea & Araque, 2005). In turn, cells 
develop a considered Ca2+ response and transmit it to other cells. Such mechanisms might 
be important to synchronize Ca2+ response in astrocytic cell populations and consequently 
in synaptic networks (Halassa et al., 2006). 
 
 
5.3 A1R-A2 AR cooperation in Ca2+  signalling modulation 
The second aim of this project was to analyze if cooperation between adenosine A1R and 
A2AR is required for Ca
2+ signalling modulation. Experiments were focused in A1R and A2AR 
because these receptors have high affinity for adenosine and it is known that the 
cooperation between these receptors exists, namely in astrocytes, to modulate GABA 
uptake (Cristóvão-Ferreira et al., 2011). A similar cooperation mechanism might be 
involved in Ca2+ signalling modulation.   
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Here it was shown, using a combination of selective agonists and antagonists for 
adenosine receptors, that the potentiation observed for both CADO, unselective ADOR 
agonist, and CGS 21680, A2AR selective agonist, is completely reverted not only by SCH 
58261 (50 nM), an A2AR selective antagonist, but also by DPCPX (50 nM), an A1R selective 
antagonist. This data strongly suggests that the modulation mediated by adenosine, via 
A2AR, is dependent on A2A and A1 receptor activation, which provides strong evidence for 
cooperation and/or interaction between these two receptors.  
These results indicate a situation of cross-antagonism, where conformational changes 
induced by one of the A1R or A2AR antagonists prevent the effect mediated by the 
complex. Similar results were reported by Cristóvão-Ferreira et al. (2011), where A1R or 
A2AR individual blockade completely prevented modulation of GABA uptake by adenosine. 
The cross-antagonism observed between the two receptors might indicate A1R-A2AR 
heteromerization (Ferrada et al., 2009; Moreno et al., 2010; Cristóvão-Ferreira et al., 
2011) and should be further explored.  
Again, our findings refute results obtained by Alloisio et al. (2004), who saw no inhibition 
of the facilitatory effect mediated by CADO (10 μM) in the presence of DPX (10 μM), a A1R 
selective antagonist. Such contrasts in results might be due to drug application, as these 
authors described DPX topical application for about 200 seconds, which is very different 
from the drug perfusion method used here. Beyond all the discrepancies in experimental 
protocols, it should be kept in mind that the dual-modulatory role of adenosine might 
account for the variable effects reported under different experimental conditions. 
An interesting observation was that DPCPX, an A1R selective antagonist, seems to be more 
effective in reverting the A2AR-mediated facilitation of Ca
2+ response, when compared to 
SCH 58261, an A2AR selective antagonist. These results can be indicative of some kind of 
modulatory effect that is mediated by A1R. To further explore this issue more experiments 
have to be performed in order to understand the role of A1R in Ca
2+ signalling modulation 
and test if the A1R-mediated modulatory effect is also inhibited when A1R and A2AR are 
individually antagonized. 
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The contribution of other adenosine receptors for this modulatory effect cannot be ruled 
out and should be evaluated in the future. Low-affinity A2BR, similarly to A2AR, are also 
positively coupled to cAMP (Peakman & Hill, 1994). Moreover, these receptors were 
proposed to mediate potentiation of ATP-induced Ca2+ responses in cortical (Alloisio et al., 
2004) and cerebellar astrocytes (Jiménez et al., 1999). These two authors also reported no 
potentiation of Ca2+ transients mediated by A1R. Nonetheless, it is fundamental to dissect 
the role, possibly inhibitory, of these receptors in Ca2+ signalling modulation. A1R are not 
only known to mediate an opposite inhibitory effect, mediated by Gi-proteins, but also 
seem to cooperate with A2AR in modulatory processes, namely, in astrocytes (Cristóvão-
Ferreira et al., 2011). A3R contribution should also be dissected, as in previous works was 
observed that IB-MECA, an A3R selective agonist, is responsible for enhancing the ATP-
induced Ca2+ responses in tracheal smooth-muscle cells (Michoud et al., 1999). Alloisio et 
al. (2004) reported no modulatory effect of A3R upon the initial Ca
2+ peak. 
In order to understand if the potentiation of Ca2+ responses by adenosine is dependent on 
extracellular Ca2+, further experiments have to be performed. On the one hand, it was 
already shown that for cortical and cerebellar astrocytes, potentiation of ATP-induced 
Ca2+ responses by CADO and Ap5A (diadenosine pentaphosphate, activates P2R), 
respectively, is independent on extracellular Ca2+, which indicates a purely metabotropic 
mechanism (Jiménez et al., 1998; Alloisio et al., 2004). On the other hand, Michoud et al. 
(1999) saw that the facilitation of ATP-induced Ca2+ responses by adenosine, in tracheal 
smooth-muscle cells, depends on extracellular Ca2+.  
 
 
5.4 Physiological importance of Ca2+  signalling modulation by ADOR  
Still an unexplored issue is the functional significance, in the brain, of the modulation 
effect resulting from the cross-talk between nucleotide and nucleoside receptors. The 
modulatory effect described here might be of particular importance in pathological 
situations, where both ATP and adenosine accumulate in the extracellular space (Fields & 
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Burnstock, 2006; Sebastião & Ribeiro, 2009b). Nonetheless, it might also be a significant 
regulatory mechanism in opposite situations, when the extracellular levels of ATP drop 
below a certain level. In this case adenosine production might function as a compensating 
mechanism, sensitizing astrocytes for ATP, and compensating its lower levels. 
In astroglial cells, ATP seems to prompt phenomena such as astrogliosis, and 
consequently cell proliferation or apoptosis, by eliciting a change in the internal cellular 
Ca2+ dynamic (Neary et al., 1996). Adenosine receptors in astrocytes may play a pivotal 
role in regulating the Ca2+ patterning and therefore differential activation of transcriptions 
factors (Dolmetsch et al., 1997).   
Concerning cooperation among adenosine receptors, Cristovão-Ferreira et al. (2011) 
proposed that the heteromer A1R-A2AR, which mediates both potentiation and inhibition, 
might operate as a dual amplifier to control GABA levels at synapses. It is structurally 
advantageous for cells to contain a single complex that mediates both positive and 
negative modulation, allowing a tight regulation and smooth transition between states. In 
addition, it would be even more advantageous for cells if the same receptor complex 
modulates several phenomena, such as, neurotransmitter uptake and gliotransmitter 
release by astrocytes, the latter via Ca2+ signalling modulation, the mechanism disclosed 
here.  
The transition between activation states, mediated by such a complex, was shown to be 
dependent on adenosine extracellular levels (Ciruela et al., 2006; Cristóvão-Ferreira et al., 
2011). This would allow a fine modulation of Ca2+ signalling under different physiological 
situations. For example, adenosine receptors, might mediate differential Ca2+ signalling 
regulation in response to low or high neuronal activity that is sensed via neuronal 
released-ATP, which is instantaneously converted into adenosine.  
Ciruela et al. (2006), have specifically shown that A1R-A2AR cooperation dual-modulates 
glutamate release in striatal nerve terminals according to synaptic adenosine levels. In 
astrocytes, ATP-mediated Ca2+ signalling is known to be responsible for triggering 
glutamate release (Newman, 2003). In addition, adenosine was shown to stimulate 
astrocytic glutamate release via A2AR in the hippocampus (Nishizaki, 2004), modulating 
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cellular communication. Now that A1R-A2AR cooperation in Ca
2+ signalling modulation in 
astrocytes was uncovered, we might be unveiling an indirect neuromodulatory 
mechanism by which adenosine dual-modulates Ca2+ signalling, and consequently 
gliotransmission. The role of A1R, per se, in Ca
2+ signalling modulation, as well as, of other 
adenosine receptors present in astrocytes, namely A2BR and A3R, needs further 
elucidation.  
As it is now coming to light, communication between cells is very complex. Modulation of 
Ca2+ excitability by adenosine can be envisioned as a way for astrocytes to regulate Ca2+ 
patterning and ultimately cellular communication. Furthermore, the cooperation between 
adenosine receptors, explored here, adds an extra level of modulation to communication 
between cells. 
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6 Conclusions 
The work here reported clearly shows that adenosine strongly enhances ATP-induced Ca2+ 
responses and that this effect is mimicked by selective activation of A2AR. Furthermore, 
the potentiation induced by adenosine is completely reverted by A2AR selective blockade. 
Therefore, it is concluded that adenosine potentiates Ca2+ signalling via A2AR.  
In addition, it was demonstrated that the facilitatory effect mediated by adenosine is also 
completely reverted by A1R selective blockade. Altogether, these data suggest that both 
A1R and A2AR activation is required for Ca
2+ signalling modulation by adenosine, providing 
a strong evidence for A1R-A2AR cooperation in cortical astrocytes.  
 
Here, a new modulatory mechanism mediated by adenosine was, therefore, 
characterized. Thus this purine acts not only as a neuromodulator, a well known action of 
adenosine, but also more broadly as a glial modulator, regulating the astrocytic Ca2+ 
excitable mechanism and consequently gliotransmission and cellular communication. The 
uncovering of an A1R-A2AR dual-modulatory complex adds an extra level of complexity to 
cellular communication, producing new shades of astrocytic responses.  
 
 
As an overall conclusion, adenosine, through A2AR activation, potentiates ATP-induced 
Ca2+ signalling in primary cortical astrocytes. Furthermore, A1R-A2AR cooperation is 
required for this modulation (Figure 6.1). 
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Figure 6.1 – Schematic representation of the mechanisms, here uncovered, involved in Ca
2+
 
signalling modulation mediated by adenosine receptors. 
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